journal of pharmacy practice and research · 2016-10-30 · journal of pharmacy practice and...

JOURNAL OF

Pharmacy Practice and Research

Cumulative Subject Index 1994-2014

Volumes 24-44

Journal of Pharmacy Practice and Research: Cumulative Subject Index 1994–2014 2

Journal of Pharmacy Practice and Research: Cumulative Subject Index 1994–2014

1st Term 2nd Term 3rd Term Year Page

A PINCH drug information pharmacy services – after hours 2014 201

Abnormal laboratory results, 3rd ed Kellerman G, editor [book review] 2011 330

Abstinence therapies methadone, naltrexone buprenorphine 2006 136

Abstracts APSM 1993 papers 1994 206

Abstracts SHPA Branch Conferences 1994 papers and posters 1995 61

Abstracts SHPA Branch Conferences 1996 papers and posters 1997 60

Abstracts SHPA Federal Conference 1993 papers and posters 1994 95

Abstracts SHPA Federal Conference 1995 papers and posters 1996 151

Abstracts – trends congresses and conferences –

Australia

paediatrics 2014 22

Academic detailing co-ordinated care national co-ordinated care trial 2001 13

Academic detailing elderly evaluation of impact 2003 114

Accidental falls hip fractures – etiology – in old age accidental falls 2013 265

ACE inhibitors clinical and prescribing data collated by pharmacists 2006 275

ACE inhibitors gynaecomastia [inform] 1995 292

ACE inhibitors myocardial infarction 1995 511

ACE inhibitors myocardial infarction Royal Brisbane Hospital 2002 232

ACE inhibitors nephroprotective effects diabetic renal disease 1995 410

Acetylcysteine nebulised effect on sputum sample quality microbiological analysis 2009 24

Acid-base and biochemical status intravenous chloride load intensive care unit patients 2008 296

Acute adrenal insufficiency peri-operative withholding corticosteroids 2005 311

Acute agitation in the ED midazolam vs droperidol cost analysis 2012 11

Acute coronary syndrome aspirin, clopidogrel [letter] 2006 79

Acute coronary syndromes antiplatelet therapy review 2000 270

Acute renal failure diuretics, NSAID, COX-2 inhibitors,

ACEI, ARA

triple whammy 2008 280

Acute respiratory distress syndrome methylprednisolone [letter] 2013 248

Administration support technician 1996 70

Administration, intravenous infusion pumps professional compliance 2013 279

Advanced clinical pharmacy training [letter] 1997 412

Advanced Pharmacy Practice

Framework

Advanced and Consultant Level

Framework tool

transferability of knowledge and

skills

2012 261

Adverse drug event sulfur compounds – adverse effects [letter] 2013 332

Adverse drug reaction reporting between hospitals and GPs 2001 134

Adverse drug reaction reporting hospital pharmacists, doctors 2005 9

Adverse drug reaction reporting Melbourne teaching hospitals 1994 237

Adverse drug reactions case reports [letter] 1997 471

Adverse drug reactions clinical indicators e-codes to identify ADRs 2001 98

Adverse drug reactions documentation 1995 502

Adverse drug reactions drug-related problems interpretation, design of studies 2002 235

Adverse drug reactions educational tool ADR subcommittee 1999 220

Adverse drug reactions factors influencing reporting teaching hospitals 2004 32

Adverse drug reactions hospital 1994 237

Adverse drug reactions identification with ICD-10-AM clinical coding surveillance 2009 19

Adverse drug reactions improve detection and reporting ADE trigger tool 2007 225

Adverse drug reactions labels, medical records review 1994 333

Adverse drug reactions model for informing patients ADR alert card 2012 95

Adverse drug reactions paediatrics frequency 2003 106

Adverse drug reactions patient recruitment study 2000 175

Adverse drug reactions pattern, hospitalised children [letter] 2006 246

Adverse drug reactions polygeline documentation 2000 107

Adverse drug reactions ranitidine thrombocytopenia 2000 172

Adverse drug reactions skin review article 2003 12

Adverse effects statins, communications media [editorial] 2013 258

Adverse medication events drug-related readmissions assessment 2000 47

Adverse medication incident reporting IIMS streamlined incident reporting 2010 269

Adverse penicillin responses rechallenge patients flowchart for pharmacists 2007 200

Advertising prescription medicines consumers 2000 295

Aged care rehabilitation pharmacy costs 1996 325

Ageing skin vascular atrophy, erosion of immune

function

polypharmacy, comorbidities 2012 150

Aging gerontologic care [editorial] 2013 260




AIDS unit job exchange, pharmacists 1994 426

AIDS 2014 conference HIV therapy – Australia [review] 2014 183

Airflow chronic obstruction elderly 1994 344

Akathisia review 1994 480

Albumin trace elements incompatibility 2000 71

Albumin infusion fat emulsion destabilisation 1999 210

Alcohol and medication 1997 42

Alfentanil and morphine stability and compatibility polypropylene syringes 2003 279

Allergy penicillin, documentation 1997 296

Allied health professionals pharmacists [letter] 2009 330

Allopurinol angitis [letter] 2006 77

Alteplase urokinase thrombosed catheters [letter] 2002 94

Alteplase veno-occlusive disease bone marrow transplant 1995 547

Aluminium phosphide poisoning case report 2002 297

Alzheimer’s disease and other dementias prevention 2003 138

Alzheimer's disease drug treatment review 1994 190

Alzheimer's disease drugs in development bapineuzumab 2012 58

Alzheimer's disease elderly impaired cognition 1998 261

Alzheimer's disease pharmacological management 2003 24

Ambulatory infusion devices drug use 1999 328

Ambulatory care thromboembolism – prevention and

control

[letter] 2014 163

Ambulatory care facilities stem cells – transplantation pharmacy service 2014 105

Ambulatory or community-based care electronic health records [editorial] 2010 179

American Society of Clinical Oncology [letter] 2006 248

American Society of Clinical Oncology conference report 2004 2004 207

American Society of Hematology

Annual Meeting 2013

San Antonio Breast Cancer

Symposium 2013

[grant report] 2014 293

Amikacin aminoglycoside usage Hong Kong hospital 1997 235

Amiloride oral liquid stability 1995 19

Aminoglycoside usage in Hong Kong 1997 235

Aminoglycoside prescribing computerised AUC monitoring TCI works, ALADDIN 2012 178

Aminophylline zinc incompatibility [letter] 1996 370

Amiodarone rapid severe hypothyroidism elderly female 2009 140

Amlodipine + atenolol overdose [letter] 2013 163

Amoxycillin, clindamycin and

meropenem

stability in peritoneal dialysis solution in glucose 2.5%, 37 oC, 6 hours 2012 218

Amphotericin liposomal, caspofungin invasive aspergillosis hepatic failure 2008 223

Anaesthesia elderly 1994 430

Anaesthesia elderly patient management 1999 330

Analgesia cancer pain 1996 113

Anaphylactic shock IV vitamin K1 1997 146

Anorexia nervosa, bulimia nervosa,

binge eating disorder

older people starvation syndrome 2013 231

Anti-arrhythmics for atrial fibrillation rate versus rhythm control congestive heart failure 2010 285

Antibiotic dose and duration of therapy UTI recurrence rates, times between

recurrence episodes

elderly women in aged-care facilities 2007 108

Antibiotic guidelines surgical prophylaxis 1997 290

Antibiotic policies pharmacy resources survey 1999 92

Antibiotic prescribing emergency departments adherence to guidelines 1999 155

Antibiotic prescribing practical examples 1995 202

Antibiotic prescribing restrictions outcome 1995 139

Antibiotic prescribing patterns breast cancer plastic surgery surgical site infections 2013 101

Antibiotic prescribing policy facilitators and barriers to compliance prescribers, policymakers 2013 32

Antibiotic prophylaxis surgical 1999 5

Antibiotics interventions management team 1999 36

Antibiotics paediatric appendectomy procedures impact, educational program 2005 21

Anticholinergic burden of medications cognitive impairment in the elderly Fox list 2013 202

Anticoagulation elderly 1997 328

Anticonvulsants SSRIs [inform] 1996 587

Anticonvulsants – therapeutic use hospitalisation epilepsy – drug therapy 2014 83

Antidepressants augmentation with pindolol review 1999 146




Antidepressants elderly depression 1998 187

Antidepressants minimising drug interactions patient cards 1998 259

Antidepressants new 1996 98

Antidepressants review of use 1994 250

Antifungal treatment guidelines immunosuppressed patients amphotericin 2010 119

Antihistamines non-sedating cardiotoxicity [inform] 1995 193

Antihistamines non-sedating premedication in oncology pts 2002 108

Antiinfective agents – administration

and dosage

inappropriate prescribing drug resistance, microbial 2013 261

Antimicrobial resistance conference report 2001 60

Antimicrobial stewardship antimicrobial drug resistance clinical leadership 2010 19

Antimicrobial stewardship program barriers and indicators antimicrobial prescribing 2011 37

Antimicrobial stewardship programs Australian hospitals multidisciplinary teams 2011 92

Antimicrobials appropriate prescribing practical examples 1995 202

Antimicrobials Aust. Soc. for Antimicrobials [letter] 2000 290

Antimicrobials pneumonia, community-acquired DUE 1999 317

Antiplatelet therapy coronary, acute syndromes review 2000 270

Antipsychotic prescribing children and adolescents physical health and adverse effects 2008 9

Antiretroviral therapy HIV therapy – lifelong use [editorial] 2014 181

Antiretroviral therapy HIV therapy – United States [editorial] 2014 177

Antiretroviral therapy adherence HIV-positive patients [letter] 2013 79

Antithrombotic drug combinations bleeding complications Australian reports 2008 32

APAC guidelines PBS in hospitals hospital/community bridge 1998 153

APAC guidelines recommendations consumer product information 1996 295

APAC guidelines survey implementation levels 2003 93

APEC national competency assessment tool [letter] 1997 158

Approved product information electronic sources currency 2005 295

APSA Scientific Meeting 1995 papers 1996 496

APSA Scientific Meeting 1995 posters 1996 598

APSA Scientific Meeting 1996 (supplement) 1996 1S

ARID imported drugs survey, pharmacy departments 1995 32

Artemether-lumefantrine malaria 2006 134

Aseptic dilutions accuracy 1996 254

Aseptic dispensing audit quality assurance 1998 329

Aseptic dispensing isolator 1996 556

Aseptic manufacture photokeratitis exposure to UV light 2010 222

Aspirin antithrombotic elderly 1997 328

Aspirin sneezing case report 2004 218

Assessment tool competency APEC/APRA [letter] 1997 158

Asthma inappropriate prescribing medication therapy management 2014 195

Asthma MDI-spacer vs nebuliser literature review 2001 189

Atrial fibrillation anticoagulation elderly 1997 328

Atrial fibrillation elderly long-term antiarrhythmics 2001 93

Aust Clinical Pharmacy Award 1998 Chris Alderman oration 1999 29

Aust Clinical Pharmacy Award 1999 Kingsley Coulthard oration 2000 19

Aust Clinical Pharmacy Award 2000 David Cosh oration 2000 283

Aust Clinical Pharmacy Award 2001 Jeff Hughes oration 2002 7

Aust Clinical Pharmacy Award 2002 Debra Rowett oration 2002 269

Aust Clinical Pharmacy Award 2003 Ian Coombes oration 2003 305

Aust Clinical Pharmacy Award 2004 Michael Dooley oration 2004 316

Aust Clinical Pharmacy Award 2005 Simone Taylor oration 2005 323

Aust Clinical Pharmacy Award 2006 Kirstie Galbraith oration 2006 313

Aust Clinical Pharmacy Award 2007 Neil Cottrell oration 2007 319

Aust Clinical Pharmacy Award 2008 George Taylor oration 2008 305

Aust Clinical Pharmacy Award 2009 Susie Welch oration 2009 313

Aust Clinical Pharmacy Award 2010 Garth Birdsey oration 2010 315

Aust Clinical Pharmacy Award 2011 Greg Roberts oration 2011 307

Aust Clinical Pharmacy Award 2012 Jason Roberts oration 2012 308

Aust NZ Intensive Care Society annual scientific meeting oration 2006 44

Australian Clinical Pharmacy Award

2013

Sasha Bennett oration 2013 309

Australian hospitals funding medicines State and Commonwealth 2011 12




Australian law synthetic cannabinomimetic [report] 2014 238

Australian Pharmacy Council oversupply of pharmacists pharmacy university programs 2010 262

Australian Pharmacy Council pharmacy programs/ schools academic staff 2011 259

Australian pharmacy law and practice Low J, Hattingh L, Forrester K [book review] 2010 82

Australian public hospital clinical, distribution service delivery update of 2001 survey 2004 114

Australian public hospital pharmacy workforce in 2007 2009 28

Australian public hospital pharmacy workforce survey 2003 2004 104

Australian public hospital pharmacy workforce survey 2005 2006 103

Automated drug distribution hospital 2000 94

Automated drug distribution teaching hospital 2000 141

Automated drug distribution unit dose, review 1995 230

Awards availability SHPA 1995 286

Awards objectives, scope, administration SHPA 1995 187

Awards program SHPA 1997 351

Awards program, details, instructions SHPA 1995 267

Azathioprine hepatotoxicity case report 2000 58

Azithromycin warfarin interaction 1999 159

Babies herbal products [inform] 1995 191

Bar coding drug contamination drug packaging 2014 17

Bedside medication lockers [letter] 2006 81

Behavioural change theory educational campaigns suboptimal prescribing 2010 43

Behavioural symptoms of dementia managing [letter] 2005 327

Benzodiazepine prescribing residential aged care facilities insomnia, dementia 2012 287

Beta-adrenoceptor antagonists lipophilicity new clinical classification 2007 98

Beta-blockers treatment of heart failure elderly 2006 229

Beta-lactam antibiotics continuous infusion vs bolus dosing serum and tissue concentrations 2009 219

Beta-lactam dosing critically ill patients [letter] 2007 333

Binding parabens, carboxymethylcellulose oral liquid formulations 1996 552

Bioequivalence pharmacokinetic, pharmacodynamic

principles

methods, drug-concentration time

profiles

2004 195

Biofilms infection control role in infection 2002 153

Biological drugs coming of biosimilars protein-based therapies 2008 137

Biotechnology challenges 1996 74

Biotechnology opportunities, skills 1996 79

Bipolar disorder lithium erythrocyte concentration lithium-induced neurotoxicity 2005 103

Black James or Joseph? [letter] 1996 673

Bleomycin dosage nomenclature [letter] 1998 211

Blood transfusion refusal erythropoietin 1997 38

Blue cohosh maternal ingestion neonatal epilepsy 2006 302

Bone marrow transplant [letter] 2005 244

Bone marrow transplant alteplase, veno-occlusive disease [inform] 1995 547

Bone marrow transplant conference report International meeting1999 1999 287

Bone marrow transplant preceptorship Shands Hospital September 2003 2004 129

BPH and prostate cancer pharmacological management 2001 115

BPS certification nuclear pharmacy report 2002 301

BPS certification oncology [letter] 2004 158

BPS certification oncology examination process 1999 338

BPS certification oncology specialisation 2000 118

BPS certification pharmacotherapy report 2001 223



BPS certification pharmacotherapy and psychiatry Australian perspectives 1998 334

BPS exam Australian version [letter] 2005 330

Brain injury, hypoxic serotonergic agents dopaminergic agents 2000 202

Breast cancer adjuvant therapy chemotherapy, hormone therapy biological therapy, older people 2007 321

Breast milk drug timing of dosing and feeding 1995 295

Breast milk drugs, dosage [letter] 1996 288

Breast milk timing of dosing and feeding [letter] 1995 486

Breastfeeding drugs [letter] 1996 454

Breastfeeding sumatriptan [inform] 1996 460

Breastfeeding use of medication information resources 2001 207

Breastfeeding and drugs Andriske L, author 1998 147




Calcium ions incompatibility sulfate ions 2002 307

CAM hospital pharmacist practice attitude, perception, knowledge 2007 220

CAM in older people 2005 63

CAM warfarin knowledge and use, adverse events 2011 265

CAM plus warfarin INR in CAM vs non-CAM users efficacy and adverse drug events 2010 294

Cancer pain analgesia 1996 113

Cancer – complementary and alternative

medicines

patient safety education 2014 231

Cancer chemotherapy error potential 1999 100

Cancer chemotherapy drugs unapproved indications [letter] 2010 249

Cancer drugs cost pharmaceutical industry 2011 4

Cancer pharmacists group [letter] 2007 81

Cardiac disease role of clinical pharmacist Brisbane Cardiac Consort 2002 17

Cardiac rhythm disturbances management in the ageing heart 2008 312

Cardiovascular diseases – prevention

and control

Statins – administration and dosage [letter] 2014 64

Cardiovascular risk reduction extreme elderly modifiable risk factors 2013 62

Career opportunities all-rounders Series 1999 48

Career opportunities business development manager Series 1999 177

Career opportunities editing Series 2000 25

Career opportunities hospital pharmacy Series 1998 224

Career opportunities hospital pharmacy Series 1999 342

Career opportunities professional association Series 1999 46

Career opportunities Project Officer, PSA Series 1999 47

Career opportunities public health pharmacy practice Series 1999 118

Career opportunities radiopharmacy Series 2000 74

Career opportunities rural health education Series 1999 117

Career opportunities US study research fellowship 1999 344

Career satisfaction Indian pharmacists [letter] 2005 333

Careers clinical pharmacy 1998 269

Careers clinical pharmacy 1998 439

Careers education university joint appointments 1998 369

Careers general 1998 267

Careers government drug regulation 1998 441

Careers management health economics 1998 370

Careers management professional society 1998 440

Careers private health insurance 1998 268

Careers publishing 1998 368

Case report adverse drug reactions [letter] 1997 471

Case report reporting and writing [letter] 1998 68

Casemix ethical issues 1996 136

Casemix management tool pros, cons 1996 132

Casemix national pharmacy study 1995 342

Casemix past, present, future 1996 125

Casemix technician's perspective 1996 68

Casemix classification acute care setting pharmacy 1997 302

Casemix funding [letter] 1994 282

Casemix funding CEO's perspective 1996 134

Casemix funding ethical issues 1996 136

Catecholamine excretion effects of venlafaxine 1997 232

CCGP examination geriatric pharmacy report 2001 41

CCGP examination geriatric pharmacy 2001 [letter] 2002 15

CCGP examination geriatric pharmacy 2001 [letter] 2002 95

Cefotaxime prescribing audit major teaching hospital 1994 392

Cephalothin drug utilisation review DUE 1995 238

Cetuximab extravasation perivascular tissue 2013 49

Charles Sturt University education, practice intentions first graduate cohort 2002 69

Checking prescriptions before dispensing 1997 321

Chemical modification drug delivery review 1998 165

Chemotherapy cancer error potential 1999 100

Chemotherapy diarrhoea [letter] 2000 229

Chemotherapy diarrhoea [letter] 2000 230




Chemotherapy elderly cancer 1998 124

Childhood pain international symposium 2006 multidisciplinary forum 2007 45

Chlamydia trachomatis screening, community pharmacies acceptance by pharmacists, women 2007 287

Chlamydia trachomatis screening first-void urine, low vaginal swab community pharmacy service 2013 15

Chlorhexidine antiseptic solution operating room [letter] 2010 333

Cholecalciferol (vitamin D3) liquid stability in olive oil paediatric formulations 2012 213

Chronic diseases community pharmacy medication regimen management 2009 207

Chronic heart failure barriers to medication adherence home visit by pharmacist 2010 27

Chronic heart failure medicines management pathway community liaison pharmacist 2006 175

Chronic obstructive pulmonary disease adherence to interventions patient perspective 2006 278

Chronic obstructive pulmonary disease smoking cessation elderly 2009 302

Chronic obstructive pulmonary disease smoking cessation patient perspective 2006 107

Chronic pain ketamine review 1998 94

Chronic pain management pain severity cut-points scale for mild, moderate, severe pain 2012 196

CHU Grenoble [letter] 2013 164

Ciprofloxacin seizures 1995 145

Ciprofloxacin usage community hospital 1994 318

Cisapride co-dispensing contraindicated drugs 2008 23

Cisapride overseas withdrawal local use [letter] 2001 154

Clinical drug information 1994 28

Clinical oncology report 1995 473

Clinical testing university training [letter] 1997 470

Clinical and distribution service Australian public hospitals update of 2001 survey 2004 114

Clinical drug trials hospital pharmacy services investigational drugs 2010 300

Clinical indicators adverse drug reactions e-codes to identify ADRs 2001 98

Clinical information systems medication errors patient discharge 2014 29

Clinical interventions identifying barriers to recording pharmacists' beliefs and attitudes 2009 99

Clinical pharmacist integration hospital disease management unit 2008 132

Clinical pharmacists work patterns pre-eMMs implementation medical and surgical wards 2012 134

Clinical pharmacy careers 1998 269

Clinical pharmacy careers 1998 439

Clinical pharmacy conference report International congress1999 1999 279

Clinical pharmacy conference report International congress1999 1999 281

Clinical pharmacy documentation clinical activities 2000 10

Clinical pharmacy documentation clinical activities 2000 10

Clinical pharmacy documentation survey 2000 6

Clinical pharmacy documentation survey 2000 6

Clinical pharmacy evolving area of practice India 2001 147

Clinical pharmacy extending opportunities Australian experience 1994 22

Clinical pharmacy extending opportunities Australian experience 1994 28

Clinical pharmacy future publication 2000 2

Clinical pharmacy ICD-10-AM standardisation 1999 261

Clinical pharmacy impact of service implementation Indian maternity hospital 2003 131

Clinical pharmacy India beginnings 1998 343

Clinical pharmacy India, clinical pharmacy department establishment 2002 240

Clinical pharmacy respiratory rehabilitation pharmacy input 1998 181

Clinical pharmacy review of services Kasturba Hospital, India 2003 78

Clinical pharmacy rural vision for the future 2001 46

Clinical pharmacy services national survey 1996 416

Clinical pharmacy activities documentation pilot study 2000 150

Clinical pharmacy COSP pharmacy staffing levels shpaclinCAT 2013 91

Clinical pharmacy education and peer review evaluate performance 2003 208

Clinical pharmacy education new Victorian course 1999 95

Clinical pharmacy education resource management [editorial snapshot] 2000 46

Clinical pharmacy in Indonesia Australian hospital pharmacists pharmacy practice 2003 220

Clinical pharmacy information systems physician attitudes nurse attitudes 2013 288

Clinical pharmacy intervention poisoning India 2001 26

Clinical pharmacy practice grant [letter] 1996 373

Clinical pharmacy research Arabic countries [letter] 2013 247

Clinical pharmacy service number of beds to pharmacists ten clinical activities 2010 217

Clinical pharmacy services nursing home 1994 22

Clinical pharmacy services pharmacy technician roles aged-care inpatients 2012 125




Clinical pharmacy services time spent by pharmacists tools to record components of service 2007 102

Clinical pharmacy status Australia 1998 105

Clinical pharmacy training teaching the teacher 2003 45

Clinical pharmacy workload by patient disease classification medical and surgical patients 2008 126

Clinical skills pharmaceutical care ASHP self-study 1998 387

Clinical training programs advanced [letter] 1997 412

Clinical trial pharmacist [letter] 2007 333

Clinical trial pharmacist [letter] 2008 77

Clinical trials Int. Clinical Trials Symposium [letter] 2002 264

Clinical trials quantify hospital pharmacy workload workload measures 2007 303

Clonidine urticaria 2006 218

Clopidogrel pharmacogenomics CYP2C19 and PON1 genotyping 2011 14

Clopidogrel and aspirin emergency non-cardiac surgery algorithm for non-stented patients 2011 132

Clopidogrel metabolism PON1 polymorphisms individualised treatment 2011 258

Clopidogrel prescribing guidelines prescribing patterns 2006 40

Clopidogrel prescribing in hospital Pharmaceutical Benefits Scheme low-dose aspirin 2009 265

Closed system devices cytotoxic contamination [letter] 2009 247

Clozapine Clozaril Patient Monitoring System web [letter] 2001 56

Clozapine myocarditis [letter] 2000 72

Clozapine schizophrenia 1996 93

CMIs given to outpatients pharmacist professional judgement off-label use, patient interpretation 2013 11

Cocaine hydrochloride topical solution stability 1996 629

Cockroft-Gault equation modification of diet in renal disease drug dose calculation, renally cleared

drugs

2006 204

Cognitive pharmacy services patients' willingness to pay ambulatory care settings, USA 2003 265

Cold-chain within a hospital identification of breaches 2007 16

Collocated hospitals pharmacy services private hospital practice 2000 256

Commercialisation corporatisation, privatisation 1996 45

Communication medication counselling patient preferences 2014 213

Communication pharmacy liaison 1997 398

Communications media statins – adverse effects [editorial] 2013 258

Community healthcare practitioners drug information resources 1996 429

Community health services gerontologic care [editorial] 2014 80

Community liaison pharmacy practice Illawarra region 1999 217

Community liaison therapeutic drug monitoring digoxin 1997 435

Community pharmacists - NZ health screening medication monitoring 2014 188

Community pharmacy extemporaneous dispensing survey, Victoria 1999 196

Community pharmacy NCP Database Project [letter] 2002 177

Community pharmacy reference database national survey [letter] 2002 16

Community pharmacy reference database rationale and methods 2002 143

Community pharmacy role in promoting healthy behaviours 2007 42

Community-acquired pneumonia Antibiotic choice length of stay 2005 25

Community-acquired pneumonia review of current evidence severity assessment, antibiotic choice 2004 212

Compatibility morphine and ketamine subcutaneous infusion [letter] 1995 352

Compatibility stability, morphine tartrate polypropylene syringes 1997 207

Compatibility visual parenteral nutrition 1994 167

Competency assessment tool APEC/APRA project [letter] 1997 158

Competency mutual recognition 1998 392

Competency framework for pharmacy

services

Pacific-Island countries service based, not cadre specific 2012 268

Complementary medicine Australian veterans 2005 110

Complementary medicine cystic fibrosis prevalence of use 2002 320

Complementary medicine in Sydney 1997 367

Complementary medicine legislation [editorial snapshot] 2000 93

Complementary medicine pharmacist role, Australia [letter] 2004 73

Complementary medicine public hospitals policies 2000 23

Complementary medicine survey of use hospital inpatients 2001 110

Complementary medicine survey of women's attitudes 2003 55

Complementary medicine war veterans [letter] 2006 80

Complementary medicine warfarin interaction 2000 23

Complementary medicines Australian Register of Therapeutic

Goods (ARTG)

Listed and Registered medicines 2012 174




Complementary medicines hospital pharmacists black cohosh, glucosamine, ginkgo

biloba

2009 281

Complementary medicines oncology patients drug information pharmacist 2012 181

Complexity of older patients'

medication regimens

hospitalisation Medication Regimen Complexity

Index

2011 21

Compliance association with disease markers HIV therapy 2002 315

Compliance transdermal glyceryl trinitrate survey 1995 197

Compounding practice in community

pharmacy

pharmacists attitudes specialised and non-specialised

compounding

2007 260

Computer-assisted learning exam revision pharmacy students 1999 10

Computer-assisted learning Pharmaceutical calculations student evaluation 1998 312

Computer-based testing CGP [letter] 2007 81

Computerised prescribing physician order entry 1996 664

Computerised prescribing physician order entry order verification [letter] 1997 158

Concentrated potassium chloride identify sources of error risk reduction strategy 2006 181

Conference 23rd SHPA Federal 1997 357

Conference hospital pharmacy 1995 464

Conference SHPA Branch conferences 1994 papers and posters 1995 61

Conference SHPA Branch conferences 1996 papers and posters 1997 60,

161

Conference attendance MASCC [letter] 2005 79

Conference presentation ACPP-ESCP [letter] 2004 244

Conference presentation workshop [letter] 2004 157

Conference report 14th International AIDS conference July 2002 2004 46

Conference report antimicrobial resistance 2001 60

Conference report bone marrow transplant International meeting1999 1999 287

Conference report child and adolescent psychiatry 48th Annual Meeting (Hawaii) 2002 216

Conference report Clinical pharmacy International congress1999 1999 279

Conference report Clinical pharmacy International congress1999 1999 281

Conference report College Intern

Neuropsychopharmacologicum

23rd Congress 2003 48

Conference report CPD prerequisite for registration 2001 57

Conference report critical care 2000 289

Conference report CSHP Meeting 2000 [letter] 2001 56

Conference report European Assoc Hosp Pharmacy 2000 288

Conference report European Soc. Cardiology Congress September 2003 2004 39

Conference report FIP congress 2004 2004 297

Conference report Hawaii Int. Conf. System Sciences 2002 219

Conference report Int. Symposium on Paediatric Pain 2003 2004 48

Conference report ISOPP IV 1995 476

Conference report ISOPP VII 2000 170

Conference report ISOPP VIII oncology 2002 305

Conference report National Medicines Symposium 2002 [letter] 2002 179

Conference report paediatric oncology SIOP Congress 2000 2001 66

Conference report paediatric psychiatry CINP 2000 2001 234

Conference report paediatrics NPPG Conference 2000 2001 64

Conference report Pain, Ninth World Congress 2000 286

Conference report palliative care European Congress 2001 232

Conference report parenteral nutrition AuSPEN 2000 176

Conference report Poisons Information Centres EAPCTT Congress 2000 2001 62

Conference report symposium on cancer chemotherapy September 2003 2004 41

Conference report therapeutic drug monitoring clinical toxicology 2000 73

Conflicts of interest drugs purchase and sponsored travel partnership with industry 2013 8

Conflicts of interest strengths and limitations of evidence independent research, infrastructure 2013 172

Congenital heart disease parent education and counselling [letter] 2006 245

Congresses and conferences – Australia paediatrics abstracts – trends 2014 22

Constipation drug-associated older people 2000 210

Constipation educational campaign 1996 351

Constipation pharmacological management older people 2002 37

Consultative pharmacy services 1997 417

Consumer attitudes over-the-counter medicines pharmacy practice 2014 224

Consumer medicines information Australian consumers CMI 2005 94




Consumer medicines information national phone-in1997 telephone advice 1998 304

Consumer medicines information pronunciation CMI 2005 293

Consumer product information action plan 1994 368

Consumer product information APAC recommendations implementation 1996 295

Consumer product information availability 1994 369

Consumer product information general information 1996 293

Consumer product information letters 1997 250

Consumer product information pharmacists' obligations 1997 46

Consumer product information readability 1997 126

Consumer product information SHPA position paper 1994 266

Consumer product information who can read it? 1997 126

Consumer product information workshop report 1994 264

Contact sensitisers guidelines safe handling 2000 216

Continuing professional development community pharmacists learning trends 2011 203

Continuing professional development conference report prerequisite for registration 2001 57

Continuing professional development educational opportunities [letter] 2010 77

Continuing professional development professional competence [letter] 2009 248

Continuing professional development professional competence [letter] 2009 327

Continuing professional development requirements for registration CPD framework 2013 213

Continuous subcutaneous infusions safe prescribing and preparation regional palliative care 2013 109

Continuum of care development of form APAC guidelines 2003 268

Continuum of care emergency department [letter] 2004 71

Continuum of care home pharmacy service medication review, liaison with health

professionals

2003 212

Continuum of pharmaceutical care APAC guidelines clinical pharmacy ward service 2009 176

Contrast media properties, adverse reactions 2005 33

Co-ordinated care academic detailing Nat. Co-ordinated Care Trial 2001 13

Co-ordinated care opportunities 1997 458

Co-phenylcaine forte spray cardiovascular effects 1995 417

Core clinical pharmacy services in 2020 plan and prioritise services 2013 9

Coronary disease – drug therapy statins – therapeutic use [letter] 2013 332

Corporatisation commercialisation privatisation 1996 45

Corticosteroid avascular necrosis [letter] 2006 164

Corticosteroid paediatric mixtures flavouring [letter] 1998 290

Corticosteroid paediatric mixtures taste, administration 1998 246

COSA conference report 1995 466

COSP neonatal and paediatric [letter] 1998 68

COSP, Drug Usage Evaluation drug utilisation data 1996 247

COSP, Outpatient Services guidelines 1994 421

COSP, Poisons Information guidelines, quality assurance 1996 442

COSP, Poisons Information information sources 1995 163

COSP, Poisons Information minimum staffing 1995 460

COSP, Psychiatric Pharmacy practice guidelines 1995 347

COSP, Rehabilitation community liaison pharmacist 1996 570

COSP, Rehabilitation guidelines, self-medication 1994 416

Cost pharmacists’ salary [letter] 1997 335

Cost pharmacy aged care rehabilitation 1996 325

Cost software pharmacy perspective 1996 315

Cost benefit unit-of-issue 1994 329

Cost of medicines Malaysia [letter] 2009 329

Cotrimoxazole hypersensitivity rapid desensitisation immunocompetent patients 2010 130

Counselling patient satisfaction survey 1999 162

Counselling patients' homes project 1998 117

COX-2 inhibitors audit of use St Vincent's Hospital Sydney 2003 74

COX-2 inhibitors drug use evaluation celecoxib, inappropriate use 2002 104

COX-2 inhibitors NSAID's audit, rural general practice 2003 70

COX-2 inhibitors oncology celecoxib [letter], [reply-letter] 2000 120

COX-2 inhibitors Thai orthopaedic outpatients cost impact 2005 115

COX-2 inhibitors use and overuse [letter] 2003 157

COX-2 inhibitors use in children and adolescents celecoxib 2002 27

Credentialing pharmacy and pharmacology -

organisations

[editorial] 2014 11




Critical appraisal original research paper 2001 200

Critical care pharmacy practice standards 2008 58

Critical care seminar September 2003 2004 71

Crystal precipitation total parenteral solution potassium sulphate 1998 444

Cultural change drug expenditure 1995 220

Cultural competence palliative care [editorial] 2014 78

Cystic fibrosis complementary medicine prevalence of use 2002 320

Cystic fibrosis North American CF conference October 2003 2004 125

Cytochrome P450 drug interactions drug metabolism 2000 146

Cytochrome P450 drug metabolism series 2000 54

Cytochrome P450 genetics of inter-individual variability 2008 226

Cytochrome P450 inter-individual variability 2009 55

Cytochrome P450 multiplicity and function 2008 55

Cytochrome P450 pharmacogenetics drug metabolism 2000 102

Cytokines drug metabolism clinical relevance 2002 147

Cytotoxic admixture cost informing consumers [letter] 2003 244

Cytotoxic chemotherapy preparation area contamination pharmacy departments 2009 117

Cytotoxic chemotherapy surface contamination [letter] 2008 79

Cytotoxic chemotherapy surface contamination [reply-letter] 2008 80

Cytotoxic contamination closed system devices [letter] 2009 247

Cytotoxic contamination commercial compounder safe handling 2011 181

Cytotoxic manufacture waste management 1999 213

Cytotoxic manufacturing [letter] 2006 166

Cytotoxic manufacturing hospital [letter] 2006 78

Cytotoxic manufacturing manufacturing complexity score workload statistics 2012 193

Cytotoxic manufacturing workload statistics 2003 68

Cytotoxic surface contamination preparation and administration sites health workers' risk of exposure 2007 271

Cytotoxic transportation [letter] 2002 178

Cytotoxics extravasation database 1998 89

Cytotoxics extravasation database [letter] 1996 372

Cytotoxics occupational health and safety exposure, monitoring [letter] 2003 159

Cytotoxics pharmacy technicians handling guidelines 1998 356

Cytotoxics safety, drug cabinets [letter] 1999 291



Daily patient report clinical pharmacists 2005 37

Danazol platelets [inform] 1995 292

Data collection study, SHPA drug utilisation, public hospital 1996 59

Data drug utilisation SHPA position statement 1996 247

Database extravasation cytotoxic drugs [letter] 1996 372

Databases poisoning [letter] 2014 162

Death – psychosocial factors Fear [editorial] 2014 75

Death – psychosocial factors health personnel [editorial] 2014 73

Decanting mixtures stock bottles [letter] 2011 79

Decision support systems, clinical inappropriate prescribing – evaluation

– in old age

polypharmacy 2013 312

Deficiencies pharmaceutical care research 1998 79

Deficits in health information exchange community pharmacy consumers quality use of medicines 2011 271

Degradation stability trials [letter] 1996 289

Delirium hospital inpatients older people 2001 35

Dementia challenging behaviours correction 1997 159

Dementia challenging behaviours pharmacological management 1997 49

Dementia neuropsychiatric symptoms pharmacotherapy 2005 228

Deprescribing frail patients in the last year of life algorithm for deprescribing 2011 146

Deprescribing reducing medications older people 2003 323

Depression new antidepressants 1996 98

Dermal lacerations, paediatric repair, topical agents 1995 356

Developing clinical practice guidelines medication management acute behavioural disturbance 2007 33

Developing countries Donating drugs, medical equipment [letter] 2007 79

Developing countries pharmaceutical policy [editorial] 2010 89

Developing countries safety [letter] 2014 60

Developmental disabilities medication reconciliation [letter] 2014 160




Devices paediatric dosing accuracy 1997 323

Devices restrictive flow infusion review 1997 115

Dexamethasone morphine, adjuvants compatibility, stability,

polypropylene syringes

1997 207

Dexamethasone oral solution, stability 1994 312

Dexamethasone dosing premature infants case report 2000 205

Dexamethasone oral solution stability 1994 312

Dexamethasone prescribing palliative care indications, adverse effects 2011 217

Dextropropoxyphene+paracetamol analgesic efficacy with multiple doses third molar dental extractions 2004 22

Diabetes ACE inhibitors nephroprotective effects 1995 410

Diabetes advances in treatment elderly 2009 63

Diabetes complementary medicine use Fremantle Diabetes Study 2003 260

Diabetes metformin [letter] 2014 289

Diabetes pharmaceutical care [letter] 2003 17

Diabetes control in hospital insulin-to-test orders prevalence, glycaemic control 2004 95

Diarrhoea chemotherapy [letter] 2000 229

Diarrhoea chemotherapy [letter] 2000 230

Diarrhoea drug-associated older people 2000 165

Dicloxacillin and magnesium IV incompatibility [letter] 2008 162

Dietary supplementation – in pregnancy professional knowledge – evaluation pharmacists 2014 113

Digoxin elderly sinus rhythm, heart failure 1997 406

Digoxin pharmacokinetics hospital and community liaison 1997 435

Digoxin pharmacokinetics optimisation of dosing digoxin toxicity 2010 50

Diluted iron polymaltose 2 mg/mL

stability

iron deficiency anaemia PVC infusion bags 2013 112

Diphosphonates – adverse effects osteoporosis – complications femoral fractures – etiology 2014 35

Direct-to-consumer advertising prescription medicines Australian consumers 2011 196

Discharge medications under the PBS patients' attitudes 2004 288

Discharge prescriptions review by ward pharmacists [letter] 2002 94

Discharge prescriptions review by ward pharmacists evaluation of impact 2001 300

Disease mongering Malaysia [letter] 2009 79

Dispensing checking prescriptions 1997 321

Dispensing errors audit [letter] 2002 261

Dispensing extemporaneous [letter] 1999 347

Dispensing near miss events Near Miss Program (PMCI) 2001 125

Dispensing errors audit [letter] 2002 261

Dispersible aspirin tablet stability room temperature, Dosette Box physical appearance 2012 204

Disposable pump SC infusion Surefuser 1998 241

Distribution ward stock, unit-supply nursing and pharmacy time,

medication errors

1997 22

Distribution systems doses missed evaluation 1998 413

Documentation pharmacists’ intervention paediatrics 2014 205

Documentation methods pharmaceutical care activities 1996 215

Dopamine Gangrene dose, infusion rate 1998 250

Dosage forms non-oral drug delivery principles, limitations 1997 313

Dosage forms oral drug delivery principles, limitations 1997 222

Dosage forms sustained/controlled-release oral delivery 1997 381

Dosage forms transdermal 1997 441

Dosage monitoring thyroxine thyroid stimulating hormone 1999 142

Dosage nomenclature bleomycin [letter] 1998 211

Dose administration aids repackaging paracetamol tablets stability 2006 25

Dose comparison fluticasone, beclomethasone,

budesonide

[letter] 2004 245

Dose omissions in hospital eMMS, MedChart non-valid omissions of high-risk

medicines

2012 264

Droperidol morphine, adjuvants, compatibility stability, polypropylene syringe 1997 207

Drotrecogin alfa severe sepsis 2006 185

Drug breast milk, dosage [letter] 1996 288

Drug breast milk, dosing time and feeding [letter] 1995 486

Drug breastfeeding [letter] 1996 454

Drug expenditure, cultural change 1995 220

Drug Highly Specialised Program [letter] 1994 175




Drug intrathecal administration [letter] 1995 174

Drug non-approved consensus indications [letter] 1994 280

Drug non-approved indications [letter] 1994 356

Drug off-label use outpatient setting, pilot study 1995 527

Drug patients' understanding of allergy documentation 2005 276

Drug periodontum 1994 80

Drug pregnancy/lactation Motherisk Program, Canada 2001 230

Drug Special Access Scheme written consent [letter] 1994 281

Drug therapeutics information service 1994 28

Drug administration enteral feeding guidelines 1997 214

Drug administration pilot study, nurses sole responsibility, errors 1994 491

Drug administration self-medication [letter] 1995 52

Drug administration unit-of-issue, geriatric unit time, cost-benefits 1994 329

Drug administration errors medication drawers patients' names 1998 185

Drug adverse reactions case reports [letter] 1997 471

Drug and therapeutics committee implementation of decisions intervention strategies 2004 178

Drug and therapeutics committee Nepal [letter] 2006 81

Drug and therapeutics committees improving decision outcomes 2003 65

Drug combinations reference of incompatibility reactions [letter] 1997 470

Drug contamination drug packaging bar coding 2014 17

Drug delivery 11. Peptides and proteins Review 1999 20

Drug delivery 12. Gene therapy Review 1999 149

Drug delivery chemical modification review 1998 165

Drug delivery modified-release parenterals review 1998 99

Drug delivery mucosa (eye, vagina, uterus, rectum) review 1998 318

Drug delivery non-oral dosage forms principles, limitations 1997 313

Drug delivery nose and mouth mucosa review 1998 236

Drug delivery oral dosage forms principles, limitations 1997 222

Drug delivery palliative care 1994 74

Drug delivery pulmonary review 1998 19

Drug delivery site-specific (small molecules) review 1998 417

Drug delivery sustained/controlled-release oral dosage forms 1997 381

Drug delivery transdermal 1997 441

Drug development process pivotal clinical trial Clinical Trial Action Group 2011 94

Drug distribution automated system hospital 2000 94

Drug distribution automated system teaching Hospital 2000 141

Drug distribution automated systems, unit dose 1995 230

Drug distribution current practice review 1995 119

Drug distribution individualised medication errors 1994 387

Drug distribution ward stock, unit-supply 1997 22

Drug expenditure cultural change 1995 220

Drug information international network conference 1998 115

Drug information pharmacy services – after hours A PINCH 2014 201

Drug information resources use by community practitioners 1996 429

Drug information review of service India 2001 144

Drug information service closed VDIC 1998 391

Drug information centre Australia, survey 1995 433

Drug information centre development and use India 2002 24

Drug information service hospital pharmacists use and opinion 2005 284

Drug information service South Indian teaching hospital evaluation 2005 40

Drug interaction perhexiline paroxetine 1998 254

Drug interaction alerts dispensing, prescribing software [letter] 2009 81

Drug interactions antiepileptics, chemotherapeutic

drugs

pharmaceutical review 2011 42

Drug interactions cytochrome P450 drug metabolism 2000 146

Drug interactions databases and electronic alerts E-drug interaction alerts 2011 7

Drug interactions Indian community pharmacies prescriptions [letter] 2005 332

Drug metabolism cytochrome P450 series 2000 54

Drug metabolism cytokines clinical relevance 2002 147

Drug overdose hospital admissions 1994 231

Drug packaging bar coding drug contamination 2014 17

Drug prescribing vancomycin improving 1998 400




Drug resistance, microbial antiinfective agents – administration

and dosage

inappropriate prescribing 2013 261

Drug stability penicillin G – administration and

dosage

sodium citrate 2014 26

Drug stability phenylpropanolamine –

administration and dosage

syringes 2014 89

Drug stability testing formulated products 1995 405

Drug storage medication errors different sites 1996 234

Drug supply cost comparison nursing home 1994 471

Drug therapy vascular diseases, stomach diseases octreotide acetate – therapeutic use 2013 297

Drug therapy – statistics and numerical

data

drug therapy – statistics and

numerical data

hip fractures – etiology – in old age 2013 265

Drug treatment Alzheimer's disease 1994 190

Drug use evaluation COX-II inhibitors celecoxib, inappropriate use 2002 104

Drug use evaluation gentamicin 1997 133

Drug use evaluation ipratropium two tertiary referral hospitals 2001 279

Drug use evaluation octreotide 1997 250

Drug use evaluation ondansetron postoperative nausea & vomiting 2007 11

Drug use evaluation psychotropic drugs survey 2000 196

Drug use evaluation risperidone 1997 33

Drug use evaluation terminology 2000 279

Drug use evaluation vancomycin guidelines local & published 1998 394

Drug use evaluation models Australia and New Zealand collaborative model successful 2010 15

Drug use indicators private hospitals 2005 28

Drug use quality federal government contribution 1998 78

Drug use quality hospital practice indicators manual 1998 38

Drug use quality prescribing review 1998 24

Drug utilisation data SHPA position statement 1996 247

Drug utilisation data collection feasibility study 1996 59

Drug utilisation evaluation program hitchhiker's guide 1995 315

Drug utilisation review cephalothin 1995 238

Drug utilisation review filgrastim 1995 336

Drug-drug interactions pharmacokinetic [letter] 2011 77

Drug-related hospital admissions identifying via coding 1998 7

Drug-related readmissions, unplanned 1995 400

Drug-related admissions elderly acute unit 1998 359

Drug-related admissions hospital drug overdose 1994 231

Drug-related admissions unplanned hospital 1999 84

Drug-related problems adverse drug reactions interpretation, design of studies 2002 235

Drug-related problems clinical pharmacists' interventions India 2003 272

Drug-related readmissions adverse medication events assessment 2000 47

Drugs and delirium in older people definition, diagnosis risk factors, precipitants 2011 233

Drugs imported Australian Register [letter] 1994 440

Drugs imported labelling [letter] 1996 673

Drugs imported survey hospital pharmacy departments 1995 32

Drugs, prescription self-medication psychiatric units – South Australia 2013 269

Dyskinesia tardive lithium [inform] 1995 192

Dyslipidaemia treatment older people 2002 188

Dyspnoea nebulised morphine pilot study, palliative care 1996 545

Early career pharmacy experiential placements [grant report] 2014 291

Economics health introduction 1994 34

Economics pharmacoeconomics 1994 38

Editing career opportunities series 2000 25

Editorial 21st Federal Conference 'This is Your Journal Calling' 1994 7

Editorial academic detailing educational outreach 2002 87

Editorial academic detailing service DATIS 1999 195

Editorial academic practitioner Pharmacy education 1996 407

Editorial adverse drug events safer medicines 2006 92

Editorial adverse drug reactions where are the case reports? 1997 287

Editorial AJHP readership survey 1994 469

Editorial antibiotic resistance vancomycin 1996 521




Editorial Australian medication safety

framework

ACSQH 2009 258

Editorial Australian pharmacy education 1996 405

Editorial available evidence, clinical practice NICS 2005 173

Editorial bar code medication administration CPOE 2005 257

Editorial change of title of Journal to JPPR 2001 255

Editorial clinical governance health service delivery 2006 174

Editorial clinical pharmacy formulation science 2006 172

Editorial clinical pharmacy medication reviews 2000 250

Editorial clinical pharmacy parenteral therapy 2003 256

Editorial clinical pharmacy underdeveloped countries 2001 90

Editorial clinical pharmacy intervention study 2004 89

Editorial clinical pharmacy services coding 1997 425

Editorial clinical pharmacy services evidence-based 2004 173

Editorial clinical pharmacy services justification — a new twist? 1994 305

Editorial clinical pharmacy services QUM 2004 90

Editorial clinical pharmacy services standardised documentation 1994 149

Editorial clinical pharmacy services, staffing hospital mortality rates 2007 256

Editorial clinical training pharmacy students 2007 172

Editorial Code of Ethics SHPA 2006 7

Editorial cogito, ergo, sum 1996 210

Editorial complementary medicines classification 2005 263

Editorial compounded sterile preparations harm or kill patients 2008 173

Editorial conference 25th SHPA Federal 2001 91

Editorial conjoint appointments Queensland perspective 1997 7

Editorial constitution SHPA 2000 89

Editorial consultant pharmacy clarifying the issues 1995 217

Editorial consumer product information education or information 1994 229

Editorial continuing professional development 1996 623

Editorial continuing professional development SHPA CPD program 2007 89

Editorial continuity of pharmaceutical care national approach 2006 259

Editorial contracting pharmacy services 1996 523

Editorial costs, pharmacy classification system 2001 181

Editorial counterfeit drugs manufacture and distribution 2007 256

Editorial cytotoxic drug vials external contamination 2005 264

Editorial devolution of drug budget internal markets, future 1997 105

Editorial dispensing errors time for action 2001 87

Editorial disruptive innovations community pharmacy network 2009 261

Editorial drug budgets devolution and internal markets 1997 105

Editorial drug committees quality use of medicines 1996 622

Editorial drug development process clinical trial activity 2009 262

Editorial drug dosing acute kidney injury, chronic renal

insufficiency

2008 175

Editorial drug information ongoing challenge 1997 286

Editorial drug utilisation evaluation dollars or quality? 1995 309

Editorial editorials expanded section 1996 305

Editorial education CPD 2001 3

Editorial education pharmacy management program 2002 91

Editorial efficient use of healthcare resources QUM 2008 172

Editorial electronic medication management pharmacist involvement 2008 258

Editorial electronic publishing 1997 107

Editorial eliminate hospital pethidine use 2008 88

Editorial emergency medicine pharmacist role 2006 88

Editorial equity of access to pharmaceuticals Australia 2005 4

Editorial ethics hospital pharmacy 1995 9

Editorial ethics pharmacy practice 2000 40

Editorial ethics research 2008 178

Editorial ethics research 2009 11

Editorial evidence-based medicine validity, relevance 2006 94

Editorial extemporaneous compounding 1997 201

Editorial extemporaneous compounding quality control 2005 173

Editorial extemporaneous products hospital pharmacy departments 2009 5




Editorial Federal Conference 23rd 1997 357

Editorial flawed PI and CMI thyroid and adrenal medications 2007 88

Editorial Free Trade Agreement PBS 2003 256

Editorial funding pharmaceuticals QUM 2007 10

Editorial future consultant pharmacists hospital pharmacy training 2005 175

Editorial future of JPPR final editorial 2004 5

Editorial geriatric pharmacy specialisation 2000 91

Editorial GMP TGA, international involvement 1997 426

Editorial health care going, going, gone? 2002 3

Editorial health care delivery future pharmacy practice 2006 10

Editorial health care systems restructuring 1996 522

Editorial HINI pandemic influenza outbreaks vaccination by pharmacists 2009 259

Editorial hospital outpatient clinics expansion 2009 88

Editorial hospital outpatient pharmacy finding solutions 2009 91

Editorial hospital pharmacists healthcare team member 2009 256

Editorial hospital pharmacy research 1997 6

Editorial hospital pharmacy science, anti-science 1996 307

Editorial hospital pharmacy staff shortage 1999 253

Editorial hospital pharmacy future, glimpses scientific literature 2003 91

Editorial hospital pharmacy practice future 1999 2

Editorial hospital pharmacy technicians 1996 621

Editorial hospital pharmacy technicians qualifications 2005 259

Editorial hospital pharmacy, future, glimpses scientific literature 2003 91

Editorial hospital/ community divide rural and remote Australia 2003 172

Editorial hospitals and pharmacy future 2005 6

Editorial hypnosedatives elderly 2006 5

Editorial independent drug information centres FIP 2005 258

Editorial industrial relations SHPA constitution 2001 5

Editorial integrated healthcare delivery hospital pharmacy practice 2007 257

Editorial interpret clinical trials put evidence in practice 2008 91

Editorial journal changes 1995 10

Editorial Master of pharmacy curriculum clinical pharmacist 2006 172

Editorial medication errors systems approach 1997 106

Editorial medication reconciliation medication safety 2007 7

Editorial medication reviews Clinical pharmacy 2000 250

Editorial medication use safety Australia and Canada 2008 6

Editorial medicines information consumers 2006 91

Editorial Medicines management conference annual national SHPA conference 2008 261

Editorial mentoring hospital pharmacists 2010 4

Editorial methodology survey 2000 90

Editorial National credentialing program shpaClinCat 2010 6

Editorial National Inpatient Medication Chart NIMC 2006 6

Editorial National Medicines Policy quality use of medicines 2000 191

Editorial national pharmacist registration Australian Pharmacy Council 2007 172

Editorial New Zealand pharmacy education 1996 406

Editorial NSW health system Garling report 2010 8

Editorial number of pharmacy schools Australian perspective 2009 174

Editorial on a different note 1997 5

Editorial origins of the modern hospital Renaissance Italy 2007 93

Editorial over-the-counter medicines US perspective 2009 91

Editorial participants in 'medicines value chain' conferences 2003 4

Editorial patient advocacy Garling Report 2009 175

Editorial patient non-adherence to medication pharmaceutical care 2008 256

Editorial performance indicators 1994 469

Editorial performance indicators 1996 209

Editorial performance indicators another challenge? 1994 385

Editorial PHARM Committee quality use of medicines 2003 87

Editorial Pharmaceutical Benefits Scheme achieving QUM 2007 4

Editorial Pharmaceutical Benefits Scheme it's future 2001 257

Editorial Pharmaceutical Benefits Scheme public hospitals 2001 179

Editorial Pharmaceutical Benefits Scheme public hospitals 2002 255

Editorial pharmaceutical care specialisation & certification 1997 201




Editorial pharmaceutical review academia 2006 256

Editorial pharmaceutical review emergency medicine 2006 261

Editorial pharmaceutical review evidence-based practice 2006 94

Editorial pharmaceutical review hospital pharmacy manager 2006 261

Editorial pharmaceutical review national approach 2006 259

Editorial pharmaceutical review Queensland health 2006 256

Editorial pharmacist in healthcare team 2002 171

Editorial pharmacist prescribing 2004 259

Editorial pharmacist prescribing Australia 2004 4

Editorial pharmacist prescribing UK perspective 2009 7

Editorial pharmacogenetics 2008 7

Editorial Pharmacy Board of Australia national accreditation, registration 2010 10

Editorial pharmacy care 1995 117

Editorial pharmacy education future 2008 176

Editorial pharmacy education future in England 2008 259

Editorial pharmacy education future in England 2009 10

Editorial pharmacy education lifelong learning 2009 94

Editorial pharmacy practice challenge of new models 1995 501

Editorial pharmacy practice ethics 2000 40

Editorial pharmacy practice future 1999 193

Editorial Pharmacy practice health system reform 2009 4

Editorial pharmacy practice research 2000 192

Editorial pharmacy technicians 1996 621

Editorial pharmacy technicians registrations in the UK 2005 89

Editorial posttraumatic stress disorder cause, symptoms, treatment 2010 7

Editorial prescribing medication non-medical health practitioners 2008 256

Editorial pricing of generics on PBS impact on public hospitals 2007 93

Editorial psychotropic drug use 1996 210

Editorial quality and safety in health care IT, communication technology 2005 261

Editorial quality of performance outcomes 1996 308

Editorial quality use of medicines 1995 397

Editorial quality use of medicines patient's life journey 2009 172

Editorial rational use of drugs 2008 89

Editorial readership survey 1994 469

Editorial research 1997 424

Editorial research hospital pharmacy 1997 6

Editorial research papers published value, undertaking research 2006 89

Editorial research sequelae 1997 424

Editorial restructuring healthcare systems 1996 522

Editorial safer Australian health care clinical pharmacy services 2004 88

Editorial science and anti-science in pharmacy 1996 307

Editorial seamless care 1997 356

Editorial SHPA 22nd Federal Conference 1995 310

Editorial SHPA Constitution 2000 89

Editorial SHPA Constitution industrial relations 2001 5

Editorial solid organ transplant recipients clinical pharmacy services 2009 257

Editorial standards of practice pharmacy 1999 81

Editorial succession and workforce planning next generation of pharmacists 2010 12

Editorial survey methodology 2000 90

Editorial therapeutic drug monitoring clinical pharmacy 1996 305

Editorial therapeutic drug monitoring toxicology, clinical 1999 82

Editorial title of Journal AJHP to JPPR 2001 255

Editorial undergraduate pharmacist training future healthcare 2007 6

Editorial vancomycin resistance 1996 521

Editorial workforce issues hospital pharmacy 2003 172

Education campaign constipation 1996 351

Education cancer – complementary and

alternative medicines

patient safety 2014 231

Education careers university joint appointments 1998 369

Education Charles Sturt University first graduate cohort 2002 69

Education experiential teaching, learning [letter] 2002 263

Education oral antidiabetic medicines program 2005 112




Education pharmacy students [editorial snapshot] 2000 45

Education pharmacy technicians 1996 635

Education PharmD [letter] 1999 121

Education PharmD The University of Queensland 1999 284

Education rural health Series 1999 117

Education – pharmacy learning styles [letter] 2013 334

Educational tool adverse drug reactions ADR subcommittee 1999 220

Educational visits National Prescribing Service [letter] 1999 290

Elderly academic detailing evaluation of impact 2003 114

Elderly acute myocardial infarction 1995 480

Elderly admissions, drug-related acute unit 1998 359

Elderly Alzheimer's Disease 1994 190

Elderly Alzheimer's Disease Impaired cognition 1998 261

Elderly anaesthesia 1994 430

Elderly anaesthesia patient management 1999 330

Elderly anticoagulation 1997 328

Elderly antidepressants depression 1998 187

Elderly atrial fibrillation long-term antiarrhythmics 2001 93

Elderly chemotherapy cancer 1998 124

Elderly chronic airflow obstruction 1994 344

Elderly dementia challenging behaviours 1997 49

Elderly dementia correction 1997 159

Elderly digoxin heart failure in sinus rhythm 1997 406

Elderly discharged from hospital pharmacist follow-up at home 2003 176

Elderly electrolyte disturbances pharmacological aspects 1996 363

Elderly epilepsy 1994 270

Elderly erectile dysfunction 1995 168

Elderly falls community pharmacists role 2003 51

Elderly falls contribution of medication 2001 183

Elderly hormone replacement therapy 1996 564

Elderly influenza vaccination 1995 36

Elderly insomnia management 1996 462

Elderly medication health promoting 1999 273

Elderly medication outcomes improving 1999 103

Elderly nutrition 1996 278

Elderly ocular problems 1997 239

Elderly osteoporosis 1995 372

Elderly pain chronic review 1998 361

Elderly palliative care drug management 1998 45

Elderly penicillin allergy documentation 1997 296

Elderly peptic ulcer disease review 1999 40

Elderly polypharmacy medication-related problems 2014 258

Elderly post-operative pain management 1995 280

Elderly prescribing indicators hospital inpatients 2001 19

Elderly prescribing quality inpatients, survey 2003 101

Elderly tacrine for and against 1995 566

Elderly travel medicine general advice 1999 222

Elderly urinary tract infection management 1999 166

Elderly wound management 1997 461

Elderly outpatients medication-related problems risk classification 2009 109

Electrolyte disturbance abnormal renal function elderly 2009 230

Electrolyte disturbance elderly, drugs 1996 363

Electronic discharge prescribing pharmacist-initiated cardiology 2005 287

Electronic prescribing medication safety report on study tour 2003 124

E-medication management e-prescribing [letter] 2006 76

E-medication management evaluate in Australian hospitals availability, usability, capabilities 2007 49

E-medication management medication errors, patient safety pharmacists work patterns 2010 106

Emergency department antibiotic prescribing adherence to guidelines 1999 155

Emergency department pharmacy technician, role [letter] 2003 16

Emergency department prescribing, rational junior medical officers 2000 262

Emergency department role of pharmacist 2001 303

Emergency medicine pharmacy 1997 325




Emergency Medicine COSP funding for positions part-time, full-time, extended hours 2012 333

Emergency pharmacy international preceptorship [letter] 2010 76

Emergency pharmacy reversal of opioid intoxication [letter] 2009 333

Emergency service wireless communications – utilisation [letter] 2014 161

EMLA vs nitrous oxide cannulation of children emergency department 2007 281

Enalapril solution stability 1997 395

Enalapril stability oral solution from tablets 1994 151

Enoxaparin dose individualised vs conventional [letter] 2008 77

Enoxaparin dose renal function peak anti-Xa levels 2004 14

Enteral feeding drug administration guidelines 1997 214

Epidural infusions error potential [letter] 1999 346

Epilepsy elderly 1994 270

Epilepsy management older people 2002 110

Epilepsy – drug therapy anticonvulsants – therapeutic use hospitalisation 2014 83

Epoprostenol hypertension, primary pulmonary home infusion program 2000 222

Epoprostenol nebulised acute respiratory distress syndrome low dose 2011 45

E-prescribing pharmacist prospective review [letter] 2006 76

Erectile dysfunction elderly 1995 168

Ergocalciferol, cholecalciferol Ostelin formulation change [letter] 2006 246

Ergometrine inadvertent administration newborns [letter] 1996 454

Error-prone abbreviations eMMS drug names, mcg 2012 246

Error-prone prescribing abbreviations emergency department intervention to reduce incidence 2007 214

Errors nurses, sole responsibility pilot study 1994 491

Errors patient drug distribution system 1994 387

Errors potential interferon [letter] 1996 560

Errors potential, imported drugs, labelling [letter] 1996 673

Errors prescribing, dispensing, administering origin of error, risk analysis 2006 21

Erythropoietin refusal of blood transfusion 1997 38

e-script transcription service discharge prescriptions continuity of care 2009 286

E-scripts by hospital pharmacists discharged patients 2009 39

Essential drug list regulatory framework [editorial] 2010 172

Ethics casemix funding 1996 136

Ethics of studying drug safety postmarketing surveillance rosiglitazone, pioglitazone 2012 179

Ethnic community presentations National Medicines Week [letter] 1999 56

Eucalyptus oil medicine or folk remedy 1995 516

Europe palliative care 1995 272

European palliative care conference [letter] 2003 329

EVA minibags paclitaxel compatibility glucose, NaCl injections 1998 156

Evaluating new medicines processes used in North America Australian hospitals 2010 124

Evaluation drug usage SHPA standards 1996 240

Evaluation drug utilisation hitchhiker's guide 1995 315

Evidence base for clinical practice ketamine and complex cancer pain practice change 2012 91

e-warfarin initiation charts clinical decision support software [letter] 2013 161

Exam revision computer-assisted learning Pharmacy students 1999 10

Exchange AIDS unit pharmacist's role 1994 426

Exchange oncology sabbatical 1994 496

Exchange paediatrics RCH (Melbourne) & LTH (UK) 2001 44

Experiential clinical placements pharmacy student conducted DUEs placement site 2012 121

Experiential placements early career pharmacy [grant report] 2014 291

Experiential placements pharmacy students national accreditation and registration 2010 97

Extemporaneous compounding Queensland hospitals, quality, safety,

efficacy of compounded products

central manufacturing facility 2007 204

Extemporaneous compounding history changes in the APF from 1902-2012 dosage forms, ingredients,

compounding methods

2013 117

Extemporaneous dispensing [letter] 1999 347

Extemporaneous dispensing community pharmacy survey, Victoria 1999 196

Extemporaneous dosage forms pharmacy graduate competency compounding techniques 2013 19

Extemporaneous omeprazole mixtures stability and shelf-life paediatric dosing 2008 276

Extemporaneous paracetamol capsules modified-release delivery system dissolution characteristics 2004 276

Extemporaneous prescribing survey Australian general practitioners 2002 310

Extended pharmacy services collaboration, GPs and pharmacists GPs' perceptions 2007 182

EXTRA extravasation database cytotoxics [letter] 1996 372




Extravasation cytotoxics database 1998 89

Extravasation methotrexate case report 1998 430

Eye problems elderly 1997 239

Ezetimibe angioedema 2006 301

Faciola hepatica treatment [inform] 1996 273

Falls elderly contribution of medication 2001 183

Falls medications older people 2008 148

Falls prevention elderly community pharmacist 2003 51

Fat emulsion albumin infusion destabilisation 1999 210

Fear death – psychosocial factors [editorial] 2014 75

Federal government contribution drug use quality 1998 78

Feeding enteral drug administration guidelines 1997 214

Femoral fractures – etiology diphosphonates – adverse effects osteoporosis – complications 2014 35

Fentanyl nasal pharmacokinetics 2003 59

Fever neoplastic therapy [inform] 1995 293

Filgrastim DUE three hospitals 1995 336

Financial analysis in pharmacy Practice Herist KN, Rollins B, Perri M,

authors

[book review] 2011 331

FIP global hospital pharmacy practice [letter] 2008 332

FIP international pharmaceutical care [letter] 2007 80

FIP promoting professional practice 2004 43

FIP 2010 ISPW 2010 [letter] 2010 331

Flucloxacillin hepatic injury [inform] 1996 459

Flucloxacillin occupational exposure decontamination 2009 95

Flucloxacillin infusion stability elastomeric infusion devices home infusion therapy 2005 90

Flucloxacillin IV solutions stability hospital-in-the-home 2010 101

Flucloxacillin stability hospital in the home [letter] 1998 289

Fluoroquinolone prescribing India [letter] 2005 166

Flurouracil palmar-plantar erythrodysaesthesia adverse drug reaction [letter] 2002 178

Folic acid methotrexate-induced neutropenia [letter] 2005 245

Folic acid peri-conceptual period [letter] 1994 439

Foreign language medication lists language barriers medication adherence 2009 277

Formulation stability testing practical aspects 1995 405

Formulation tablets, oral solutions [letter] 1995 52

Foscarnet potassium stability [letter] 1996 560

Foscarnet potassium stability [letter] 1996 560

Frailty pharmacological management elderly 2009 147

Fred J Boyd Award 1993 Virginia Richardson adapting to change 1994 48

Fred J Boyd Award 1995 Pam Neiman challenges — a personal view 1996 148

Fred J Boyd Award 1997 Frank May pharmaceutical care 1998 34

Fred J Boyd Award 1999 Ian Brand life-changing rules advice 2000 16

Fred J Boyd Award 2001 John Low journal and other matters 2001 258

Fred J Boyd Award 2003 Mary Hemming oration 2003 299

Fred J Boyd Award 2005 Margaret Duguid oration 2005 300

Fred J Boyd Award 2007 Susan Alexander oration 2007 315

Fred J Boyd Award 2009 Kingsley Coulthard oration 2009 307

Fred J Boyd Award 2011 Bill Thomson oration 2011 302

Fred J Boyd Award 2013 Yvonne Allinson oration 2013 304

Fred J Boyd Award 2014 Lloyd Sansom oration 2014 297

Free Trade Agreement [letter] 2004 69

Frusemide vancomycin, theophylline interaction 1999 269

Funding medicines Australian hospitals State and Commonwealth 2011 12

Fungal meningitis outbreak patient safety reduce human touch points 2012 258

Fursemide tablets physicochemical stability in DAAs storage conditions 2007 178

Future hospital pharmacy conference address 1998 426

Future pharmacy services conference presentation 1999 31

Galactorrhoea risperidone-induced [inform] 1995 548

Gangrene dopamine dose, infusion rate 1998 250

Gene therapy drug delivery review 1999 149

General careers 1998 267

General Level Framework pharmacists performance professional development 2010 111




General level training program rotational training competency-based performance

development

2013 129

General practice setting primary care pharmacy practice 2014 240

General practitioners' views pharmacist prescribing 2008 96

Generic drug substitution consumer perceptions USA 2004 262

Generic medicines bioequivalence, brand substitution [editorial] 2010 90

Generic medicines knowledge, acceptance community patients 2012 283

Genomics proteomics drug development 2003 7

Genomics proteomics pharmacogenomics 2003 133,

224

Gentamicin concentration targeting babies 2000 98

Gentamicin dosing in neonates 2001 291

Gentamicin netilmicin newborn infants 2000 290

Gentamicin usage Hong Kong hospital 1997 235

Gentamicin usage Sydney hospital 1997 133

Gentamicin bolus vs infusion clinical efficacy of bolus gentamicin nursing and patient convenience 2012 200

Gentamicin dosing adherence to guidelines under-dosing 2011 275

Geranium leaves cracked nipples 1995 538

Geriatric pharmacy CCGP examination report 2001 41

Geriatric pharmacy practice guidelines statins – adverse effects – in old age 2014 138

Gerontologic care aging [editorial] 2013 260

Gerontologic care community health services [editorial] 2014 80

Ginger nausea and vomiting of pregnancy review 2004 305

Glaxo Medal of Merit 1993 Chris Alderman oration 1994 45

Glaxo Medal of Merit 1994 Roberta Lauchlan oration 1995 41

Glaxo Medal of Merit 1995 Kay Hynes oration 1996 106

Glaxo Wellcome Medal of Merit 1996 David Cosh oration 1997 15

Glaxo Wellcome Medal of Merit 1997 Susan Tett oration 1997 449

Glaxo Wellcome Medal of Merit 1998 Jeff Hughes oration 1998 325

Glaxo Wellcome Medal of Merit 1999 Jennifer Johnstone oration 2000 66

Glaxo Wellcome Medal of Merit 2000 Karen Allen oration 2001 9

GlaxoSmithKline Medal of Merit 2001 Graeme Vernon oration 2001 276

GlaxoSmithKline Medal of Merit 2002 Penny Thornton oration 2002 265

GlaxoSmithKline Medal of Merit 2003 Michael Dooley oration 2003 302

GlaxoSmithKline Medal of Merit 2004 Danielle Stowasser oration 2004 314

GlaxoSmithKline Medal of Merit 2005 Helen Dowling oration 2005 302

GlaxoSmithKline Medal of Merit 2006 Karen Kaye oration 2006 313

GlaxoSmithKline Medal of Merit 2007 Rosemary Burke oration 2007 318

GlaxoSmithKline Medal of Merit 2008 Jo-anne Brien oration 2008 305

GlaxoSmithKline Medal of Merit 2009 Naomi Burgess oration 2009 310

GlaxoSmithKline Medal of Merit 2010 Ian Coombes oration 2009 318

GlaxoSmithKline Medal of Merit 2011 Bhavini Patel oration 2011 304

GlaxoSmithKline Medal of Merit 2012 Rohan Elliott oration 2012 305

GlaxoSmithKline Medal of Merit 2013 David Kong oration 2013 307

Glyceryl trinitrate transdermal compliance survey 1995 197

Government careers drug regulation 1998 441

Government federal quality use of medicines 1996 55

Government policy manufacturer withdraws (NZ) [letter] 1998 211

Graduates Graduates Forum [letter] 2003 157

Grants Research SHPA 1999 249

Growth disorders treatment 1994 444

Guide to managing medicines where

there are no pharmacists

Andersson S, Snell B, editors [book review] 2011 165

Guideline adherence – New Zealand community-acquired pneumonia –

drug therapy

practice guidelines 2013 272

Guidelines antibiotic prophylaxis surgery 1997 290

Guidelines contact sensitisers safe handling 2000 216

Guidelines enteral feeding drug administration 1997 214

Guidelines information sources drug information centres 1995 163

Guidelines nimodipine quality use 1999 137

Guidelines ondansetron 1995 552

Guidelines outpatient services SHPA 1994 421




Guidelines patient counselling antineoplastics, SHPA 2001 51

Guidelines poisons information centres SHPA, quality assurance 1995 460

Guidelines poisons information centres SHPA, quality assurance 1996 442

Guidelines psychiatric pharmacy 1995 347

Guidelines self-administration SHPA 2002 324

Guidelines self-medication SHPA 1994 416

Gynaecomastia ACE inhibitors [inform] 1995 292

Haemophilia A treatment 1995 382

Haemophilia A treatment [letter] 1996 291

Haemorrhage – chemically induced stroke – chemically induced rivaroxaban – adverse effects 2014 129

Haloperidol stability polypropylene syringes [letter] 1997 338

Handling early phase investigational agents [letter] 1996 287

Harle's Baby's Friend safety, herbal [in reply] 1995 353

Harle's Baby's Friend safety, herbal [inform] 1995 191

Harle's Baby's Friend safety, herbal [letter] 1995 352

Harmful drug interactions aged-care facilities amiodarone, lithium, methotrexate,

verapamil, warfarin

2012 33

Harvard Medical School J Richard Hackman leadership capabilities 2011 175

Health creating a healthy future 1996 1

Health care privatisation government policy 1998 108

Health care quality ACHS 1996 86

Health care quality pharmacy 1997 244

Health care quality improvement drug use evaluation Breakthrough Series 2006 124

Health economics introduction 1994 34

Health issues new realities 1994 12

Health personnel death – psychosocial factors [editorial] 2014 73

Health policy – legislation and

jurisprudence – Malaysia

pharmacists professional role 2014 125

Health Policy Research International conference [letter] 2006 76

health professionals HIV education India 2005 291

Health screening medication monitoring community pharmacists - NZ 2014 188

Health systems HIV therapy [editorial] 2014 175

Health systems reengineering 1996 18

Health-related quality of life patients' perceptions of illness [letter] 2011 333

Heart failure digoxin sinus rhythm 1997 406

Heart failure drug therapy older people 2000 274

Heart failure management specialist multidisciplinary program medication review, dose titration,

monitoring

2009 186

Heart failure patients patient-guided diuretic dose

adjustment

hospital readmissions 2011 126

Heart lung transplantation symposium [letter] 2005 248

Heart surgery postoperative care intensive care units 2014 108

Helicobacter pylori eradication Singapore Ministry of Health clarithromycin, amoxycillin,

omeprazole

2010 194

HEPA filters testing DOP challenge [letter] 2001 154

Heparin LMWH vs unfractionated heparin [letter] 2009 165

Heparin low molecular weight elderly 1997 328

Heparin weight-based dosing protocol concordance evaluation 2005 15

Heparin weight-based drug chart [letter] 2007 78

Hepatic injury flucloxacillin [inform] 1996 459

Hepatotoxicity azathioprine case report 2000 58

Herbal Medicines [letter] 1999 346

Herbal medicines Toxicity [letter] 2000 71

Herbs & natural supplements: an

evidence-based guide

Braun L, Cohen M, authors [book review] 2010 250

Hib vaccine splenectomised patients [inform] 1995 489

High- vs standard-dose capsules pancreatic enzymes cystic fibrosis 1998 160

High-cost drugs Access decision makers' perspectives 2005 18

High-risk medicines alerts clinical relevance barriers to implementation 2010 203

Hip fractures – etiology – in old age accidental falls drug therapy – statistics and

numerical data

2013 265

Histories by pharmacist review 1995 261

History philosophy pharmaceutical research 1996 331




History philosophy pharmaceutical research 1996 337

History of pharmacy schools granting pharmacy degrees 2008 211

HIV education health professionals India 2005 291

HIV therapy association with disease markers adherence to therapy 2002 315

HIV therapy health systems [editorial] 2014 175

HIV therapy nurses [editorial] 2014 179

HIV therapy – Australia AIDS 2014 conference [review] 2014 183

HIV therapy – lifelong use antiretroviral therapy [editorial] 2014 181

HIV therapy – United States antiretroviral therapy [editorial] 2014 177

HIV treatment centres pharmacy practice United Kingdom 2003 282

HIV-positive patients long-term antiretroviral therapy [letter] 2010 78

Home health care comparison of pharmacy services US, UK, Australia 2003 128

Home medication review Australian war veterans early experience 2004 122

Home medication review continuity of care in therapeutics post-discharge from hospital 2007 22

Home medication review hospital pharmacist accreditation HMR 2003 183

Home medicines review Australian veterans medication-related problems 2013 182

Home medicines review high-risk discharged patients hospital-initiated reviews 2011 27

Home medicines review hospital-initiated bespoke referral forms 2009 269

Home parental therapy adverse drug reactions anaphylaxis kit 2008 267

Home parenteral therapy survey 1997 373

Hormone replacement therapy elderly 1996 564

Hospital immunisation program 1996 539

Hospital organisational restructuring implications for pharmacists 1996 22

Hospital ward pharmaceutical care plans 1996 221

Hospital (acute care, teaching) admissions, medication-related analysis 1999 84

Hospital (major, teaching) polypharmacy analysis 1998 432

Hospital admissions drug overdose 1994 231

Hospital admissions drug-related identifying via coding 1998 7

Hospital antimicrobial prescribing

patterns

serial point-prevalence study intervention, optimise antimicrobial

use

2007 190

Hospital discharge medication process pharmacist prescribing discharge prescriptions 2008 117

Hospital discharge process pharmacist's role 2008 114

Hospital discharge summaries transition between care settings regional hospital 2010 208

Hospital in the Home flucloxacillin stability [letter] 1998 289

Hospital in the Home pharmacy involvement, rural [letter] 1998 142

Hospital in the Home pharmacy services Survey 1999 16

Hospital pharmacists India [letter] 2005 328

Hospital pharmacists medication management residential care 1995 541

Hospital pharmacists burnout exhaustion, depersonalisation,

personal accomplishment

staff attrition, absenteeism, illness 2007 187

Hospital pharmacists' place research, clinical conference symposium 1998 348

Hospital pharmacy career opportunities series 1998 224

Hospital pharmacy Career opportunities Series 1999 342

Hospital pharmacy conferences 1995 464

Hospital pharmacy drug expenditure reporting template reporting in Australian hospitals 2007 138

Hospital pharmacy future conference address 1998 426

Hospital pharmacy imported drugs survey 1995

Hospital pharmacy performance indicators clinical & management 1998 405

Hospital pharmacy quality review 1998 226

Hospital pharmacy support staff survey 1997 430

Hospital pharmacy TAGNet Network [letter] 1999 179

Hospital pharmacy Workforce snapshot of workforce/SHPA 2002 72

Hospital pharmacy workload measurement 1997 307

Hospital pharmacy practice Fiji 1996 392

Hospital pharmacy practice locum pharmacists strategies 1998 256

Hospital pharmacy practice medication use system [editorial] 2010 174

Hospital pharmacy practice performance indicators 1996 89

Hospital pharmacy technicians [letter] 2006 164

Hospital pharmacy technicians Certificates III and IV in

Hospital/Health Service

relevance of qualifications 2012 43

Hospital pharmacy technicians enterprise bargaining agreement award 2006 32

Hospital pharmacy technicians program Charles Sturt University [letter] 2003 16




Hospital pharmacy technicians UK 2005 207

Hospital practice indicators drug use quality manual 1998 38

Hospital to residential care facilities unplanned hospital readmission continuity of care 2009 216

Hospital, teaching prescribing decisions factors influencing 1999 311

Hospital-based pre-registration training hospital pharmacy workforce [letter] 2004 70

Hospital-community interface unplanned hospital readmissions missing medication information 2011 290

Hospital-in-the-Home cellulitis management [letter] 2012 81

Hospitalisation epilepsy – drug therapy anticonvulsants – therapeutic use 2014 83

Hospitalised diabetic patients lifestyle counselling [letter] 2006 77

Hospitals penicillin allergy survey 1998 410

Hospitals – Australia pharmacy service – economics –

Australia

[editorial] 2014 4

HPV vaccination for men tenofovir gel [letter] 2010 247

HPV vaccine adverse drug reaction monitoring [letter] 2011 80

Humulin 70/30, Levemir stability after 28 days refrigeration, room temperature 2013 27

Hydrofluoric acid skin exposure first aid 1998 445

Hydromorphone nasal spray pharmacokinetics bioavailability 2008 191

Hydroxyurea skin discoloration and melanonychia [letter] 2007 82

Hyoscine morphine, adjuvants compatibility in syringes 1997 207

Hypertension management older people 2001 212

Ibuprofen-induced neutropenia adverse drug events OTC medication 2013 135

ICD-10-AM clinical pharmacy activity standardisation 1999 261

Idarubicin myeloid leukaemia acute adult 1994 159

Identification of medication errors medication safety orientation program nurses 2005 190

Imatinib peripheral oedema [letter] 2007 80

Immunisation professional role pharmacists 2013 292

Immunisation program hospital 1996 539

Immunomodulatory drugs hospital supply off-label use 2009 135

Implementation of decisions drug and therapeutics committee intervention strategies 2004 178

Imported drugs Australian hospital pharmacy survey 1995 32

Inadvertent administration ketamine instead of ketorolac [letter] 2005 79

Inappropriate prescribing drug resistance, microbial antiinfective agents – administration

and dosage

2013 261

Inappropriate prescribing medication therapy management asthma 2014 195

Inappropriate prescribing – evaluation –

in old age

polypharmacy decision support systems, clinical 2013 312

Incompatibility aminophylline elemental zinc [letter] 1996 370

Incompatibility calcium ions sulfate ions 2002 307

Incompatibility ticarcillin/clavulanate vancomycin 1997 470

Increased clinical pharmacist activities pharmacist-to-bed ratio improved discharge dispensing 2005 106

Independent older people medicines management retirement villages 2012 208

India clinical pharmacy beginnings 1998 343

Indications non-approved consensus [letter] 1994 280

Indicators clinical [letter] 1994 174

Indicators performance hospital pharmacy practice 1996 89

Individual patient use scheme financial impact approvals and submissions 2004 100

Infants – colic omeprazole proton pump inhibitor 2014 220

Infection risk titrated narcotics [letter] 1995 487

Infection control biofilms role in infection 2002 153

Inflammatory bowel disease older people 2008 234

Inflammatory bowel disease thiopurines pharmacogenetics 2005 213

Infliximab Behcet's disease case report 2002 209

Influenza vaccination elderly 1995 36

Information drug & therapeutics service 1994 28

Information quality medication liaison 1997 362

Information resources community practitioners 1996 429

Information sources, guidelines poisons information centres 1995 163

Information technology hospital pharmacy practice 1996 143

Information technology pharmacy practice [editorial snapshot] 2000 44

Infusion morphine, ketamine SC compatibility [letter] 1995 352

Infusion restrictive flow devices review 1997 115

Infusion solutions SC, osmolality, pH 1997 29




Infusion systems, plastic insulin 1995 129

Infusion devices ambulatory drug use 1999 328

Infusion pumps professional compliance administration, intravenous 2013 279

Infusions epidural error potential [letter] 1999 346

Initiatives rural [letter] 1999 291

Inpatient care and health outcomes seven days a week pharmacy service 2012 7

Insomnia elderly 1996 462

Insomnia pharmacological, non-

pharmacological management

older people 2007 236

Insulin chart for hospitalised diabetic patients impact 2009 45

Insulin concentrations plastic infusion systems 1995 129

Insulin e-learning module hospital health professionals 2009 34

Insulin aspart normal saline infusion stability 2004 11

Insulin delivery systems prefilled pens versus syringes preparation and administration times 2013 198

Insulin-to-test orders diabetes control in hospital prevalence, glycaemic control 2004 95

Int Society for Quality in Health Care conference 2012 [letter] 2013 80

intensive care units heart surgery postoperative care 2014 108

Interaction warfarin topical salicylate [letter] 1996 671

Interferon potential for error [letter] 1996 560

Interim residential care medication

administration card

medication management during

transfer to RCF

pharmacy dispensing software

integration

2012 100

International network drug information conference 1998 115

International Normalised Ratio postoperative period warfarin – administration and dosage 2013 276

International Normalised Ratio warfarin – administration and dosage warfarin – adverse effects 2013 283

International Standard Kilogram ultimate standard of mass pure silicon-28 2011 256

Internet hospital pharmacy discussion group 1997 421

Internet-based medication record virtual medication cabinet decision makers' perspectives 2005 99

Interventions antibiotic management team 1999 36

Interview Lawrence Trissel 1995 427

Intrathecal drug administration [letter] 1995 174

Intravenous antibiotics 24-hour infusor bottles [letter] 2010 77

Investigational agents early phase safe handling [letter] 1996 287

Ipratropium drug usage evaluation two tertiary referral hospitals 2001 279

Ipratropium bromide inhaled vomiting [letter] 2005 165

ISHEID 2008 HIV/AIDS research TDM of HIV drugs 2008 249

ISMP Australia options for affiliate 2008 51

Isolator aseptic dispensing small volume 1996 556

Isoniazid mixture extemporaneous stability 2005 181

ISOPP 2004 210

ISOPP symposium [letter] 2003 329

ISOPP symposium [letter] 2003 244

ISOPP 12 oncology pharmacists [letter] 2011 73

ISOPP 2010 pharmacogenomics [letter] 2010 246

ISOPP X conference report 2006 122

ISOPP/HOPA 2008 symposium [letter] 2008 250

ISOPP/HOPA 2008 symposium [letter] 2008 327

Isotretinoin pregnancy prevention [letter] 1995 539

IV administration Newborns central venous catheter 1998 177

Job satisfaction pharmacists Thailand 2003 117

Ketamine case report delirium 2002 212

Ketamine chronic pain review 1998 94

Ketamine compatibility with morphine sc infusion [letter] 1995 352

Ketamine delirium case report 2002 212

Kuhn history, philosophy research 1996 331

Labelling imported drugs [letter] 1996 673

Laboratory function tests seminar [letter] 2008 163

Lacerations repair, topical agents paediatrics 1995 356

Leadership pharmacy service – administration [grant report] 2014 167

Learning styles education – pharmacy [letter] 2013 334

Legislation complementary medicines [editorial snapshot] 2000 93

Leukaemia adult, acute myeloid idarubicin 1994 159

Liaison medication emerging philosophy 1997 403




Liaison medication information quality 1997 362

Liaison model pharmaceutical care 1996 36

Liaison pharmacy extended communication 1997 398

Lignocaine co-phenylcaine forte spray, nasal cardiovascular effects 1995 417

Lipid pharmacist non-medical prescribing for surgical

PVD patients

lifestyle advice, lipid levels, statins

initiated

2012 17

Lipophilicity beta-blockers new clinical classification 2007 98

Liposomal amphotericin B infusion-related reaction conventional amphotericin B 2013 51

Liquid amiloride tablets, powder 1995 19

Liquid formulation [letter] 1995 174

Liquid formulations tablets [letter] 1995 52

Lithium tardive dyskinesia [inform] 1995 192

Lithium concentration liquid preparations [letter] 1994 439

Locum pharmacists hospital practice strategies 1998 256

Macular degeneration age-related treatment and prevention 2004 53

Major depressive disorder escitalopram, venlafaxine, duloxetine,

mirtazapine

older people 2010 58

Malaria eradication Pakistan [letter] 2011 73

Malaysian community pharmacists dispensing separation [letter] 2010 164

Malaysian community pharmacists medicine safety Seminar [letter] 2009 245

Malaysian community pharmacists pharmacovigilance [letter] 2010 245

Malaysian general practitioners'

dispensing practices

generic and brand name medicines common cold symptoms 2013 187

Management careers health economics 1998 370

Management careers professional society 1998 440

Management expectations of technicians 1996 62

Management tool casemix 1996 132

Management challenges rural hospital pharmacy survey 1999 202

Mandatory continuing professional

development

Advanced Pharmacy Practice

Framework

shpaclinCAT 2013 175

Manufacturer withdraws (NZ) government policy provokes [letter] 1998 211

Manufacturing cytotoxic waste management 1999 213

Marketing pharmaceuticals Joachim Boldt Andrew Wakefield 2011 172

Master of Clinical Pharmacy [letter] 2005 248

Master of Public Health Monash University [letter] 2012 248

Measles, mumps, rubella vaccination controversy 1998 443

Medical emergency team calls adverse drug event reporting quality use of medicines 2007 197

Medication alcohol 1997 42

Medication elderly health promoting 1999 273

Medication in the elderly quality of medicine use 2006 58

Medication individualised profiles word processor, Medprofs 1995 26

Medication self-administration [letter] 1995 52

Medication administration errors multicentre collaborations [editorial] 2010 91

Medication counselling patient preferences communication 2014 213

Medication data privacy managing complexity 1998 2

Medication dose form modification at the bedside and pharmacy Queensland hospitals 2009 12

Medication dose omission impact of nurse education 2009 114

Medication drawers drug administration errors patients' names 1998 185

Medication errors drug storage comparison study 1996 234

Medication errors patient discharge clinical information systems 2014 29

Medication errors ward stock vs unit-supply 1997 22

Medication errors – evaluation medication reconciliation [letter] 2014 159

Medication history by pharmacists 1995 261

Medication history patient completed pre-admission clinic pharmacist 2008 216

Medication information transfer between providers and settings rural Queensland community 2012 48

Medication liaison emerging philosophy 1997 403

Medication liaison information quality 1997 362

Medication liaison services medication management acceptance and use 2002 221

Medication liaison services patient outcomes randomised trial 2002 133

Medication management better medication management

system

medical records 2000 139,

190

Medication management epilepsy, seizure, convulsion risky lifestyle behaviours 2012 291




Medication management Medication Liaison Services acceptance and use 2002 221

Medication management residential care 1995 541

Medication management in geriatrics medication management tools clinical practice 2010 36

Medication management post discharge residential care facility transition of care 2012 246

Medication misadventure risks emergency setting at-risk patients 2011 108

Medication monitoring community pharmacists - NZ health screening 2014 188

Medication nonadherence veridical beliefs intentional nonadherence 2012 6

Medication omission in the

perioperative period

standard recommendations [letter] 2013 162

Medication ordering errors audit 2001 102

Medication orders computerised physician entry [letter] 1997 158

Medication outcomes elderly Improving 1999 103

Medication reconciliation developmental disabilities [letter] 2014 160

Medication reconciliation form development [letter] 2008 162

Medication reconciliation GP medication lists older patients 2013 105

Medication reconciliation medication errors – evaluation [letter] 2014 159

Medication reconciliation national health programs – Australia [editorial] 2014 9

Medication reconciliation reducing medication errors hospital admission 2008 196

Medication reconciliation standard form [letter] 2009 165

Medication reconciliation challenges eMMS, e-discharge summaries e-discharge medicines profile 2013 25

Medication regimen complexity adherence issues patients at risk 2006 99

Medication review multidisciplinary prescribing, administration 1994 260

Medication review by GPs patient peer education QUM 2004 8

Medication review service nursing home hospital pharmacists 1999 255

Medication review services decision tree for primary and

hospital-based care

HMR, MMP, RMMR, MRP 2013 88

Medication reviews nursing home general practitioner acceptance 2002 227

Medication safety Australian hospitals 2002 11

Medication safety championed by pharmacists [editorial] 2010 176

Medication safety electronic prescribing report on study tour 2003 124

Medication safety emergency department [letter] 2005 244

Medication safety practices in the US 2002 97

Medication safety program multidisciplinary approach patient safety 2003 290

Medication Safety Self Assessment National Inpatient Medication Chart [letter] 2011 75

Medication therapy management asthma inappropriate prescribing 2014 195

Medication use Australian war veterans aged-care facilities 2008 14

Medication-related admissions, unplanned hospital (acute care, teaching) 1999 84

Medication-related problems elderly polypharmacy 2014 258

Medication-related problems non-pharmacy community services [letter] 2013 248

Medication-related problems older Indian inpatients clinical pharmacists interventions 2010 279

Medications in pregnancy time to lactogenesis post-parturition 2008 205

Medicine and Therapeutics committee Nepal [letter] 2009 162

Medicines herbal [letter] 1999 346

Medicines information services 2013 53

Medicines management pathway steps and background processes continuum of care 2004 293

Medicines prepared in hospital pharmacy departments standards 2010 133

Medicines spending trends Malaysia [letter] 2011 250

Medimate National Prescribing Service [letter] 2004 74

Medline listing Editorial Committee SHPA members 2010 264

Medprofs individualised medication profiles word processor 1995 26

Men's health community pharmacists' roles rural Victoria 2004 285

Mental health clinic pharmaceutical care 1996 250

Mental health pharmacy practice standards 2012 142

Metered dose inhalers nebulisers use in hospitals 1996 529

Metformin diabetes [letter] 2014 289

Metformin otorrhoea causality and severity 2011 49

Methadone Australian programs [letter] 1996 674

Methadone programs opportunities, hospital pharmacists addiction and chronic diseases 1998 41

Methadone programs role of pharmacy services national evaluation [letter] 2001 309

Methotrexate extravasation case report 1998 430

Methotrexate-induced neutropenia folic acid [letter] 2005 245

Methoxyflurane stability Penthrox Inhaler minimise evaporation 2009 274




Metoclopramide akathisia risk and severity 2006 194

Metronidazole neurotoxicity case report 1994 325

Midazolam in acute agitation psychiatric patients [letter] 1994 356

Midazolam morphine, adjuvants compatibility in syringes 1997 207

Midazolam oral [inform] 1995 192

Midazolam metabolism critical paediatric and adult patients pharmacokinetic variability 2009 198

Mirtazapine pedal oedema 2005 310

Mirtazapine rapid weight gain decreased physical activity 2004 308

Mitomycin-C thrombotic thrombocytopenic purpura corticosteroids, plasmapheresis 2013 221

Moclobemide overdose [inform] 1996 272

Modelling IV drug loss premature neonates caffeine, gentamicin, phenobarbitone,

vancomycin

2006 262

Modern healthcare practice attitudes and perceptions to illness [letter] 2011 332

Modified-release parenterals drug delivery review 1998 99

Molecular therapies imatinib, thalidomide adherence issues 2006 115

Monitoring digoxin hospital & community liaison 1997 435

Monitoring gentamicin teaching hospital 1997 133

Moratorium on HMRs Pharmacy Guild of Australia Community Pharmacy Agreement 2013 4

Morphine compatibility in syringes polypropylene syringes 1997 207

Morphine compatibility with ketamine sc infusion [letter] 1995 352

Morphine nebulised dyspnoea 1996 545

Morphine stability, polypropylene syringes two concentrations 1997 452

Morphine/midazolam/bupivacaine stability and compatibility of infusions 2002 65

Mucosa (eye, vagina, uterus, rectum) drug delivery review 1998 318

Multidisciplinary model Therapeutics Centre quality use of medicines [letter] 2003 158

Multiple myeloma treatment older people 2004 142

Mutual recognition competency 1998 392

Mycophenolate drug utilisation evaluation unregistered indications 2004 36

Myocardial infarction acute elderly 1995 480

N-acetylcysteine capsules stability contrast-induced nephropathy 2008 219

Narcotics orthopaedic pain post-operative 1995 13

Narcotics titration infection risk [letter] 1995 487

Nasogastric administration omeprazole 1998 174

National health programs – Australia medication reconciliation [editorial] 2014 9

National Inpatient Medication Chart Medication Safety Self Assessment [letter] 2011 75

National Medicines Week activities [letter] 1999 57

National Medicines Week ethnic community presentations [letter] 1999 56

National Medicines Week phone-in1998 [letter] 1999 55

National pharmacy preceptor training mentoring module online 2006 119

National phone-in1997 consumer medicines information telephone advice 1998 304

National Prescribing Service educational visits [letter] 1999 290

National Prescribing Service Medimate [letter] 2004 74

Nausea ondansetron protocol oncology [letter] 1995 53

Near miss events dispensing Near Miss Program 2001 125

Nebuliser metered dose inhalers use in hospitals 1996 529

Neem oil 6% + eucalyptus oil 16% Pediculus humanus var. Capitis pediculicidal, ovicidal 2012 189

Nefazodone depression 1996 98

Neonatal and paediatric COSP [letter] 1998 68

Neonatal and paediatric Pharmacists Group Conference 2006 2007 136

Neonates filtration, in-line IV therapy 1999 321

Neonates gentamicin dosing 2001 291

Neonates procedural pain [letter] 2010 81

Neoplastic fever therapy [inform] 1995 293

Netilmicin gentamicin newborn infants 2000 290

Netilmicin usage Hong Kong hospital 1997 235

Networking international collaboration 2000 4

Neuralgia – diagnosis quality of life neuralgia – drug therapy 2014 38

Neuralgia – drug therapy neuralgia – diagnosis quality of life 2014 38

Neuroleptic malignant syndrome 1994 245

Neurotoxicity metronidazole case report 1994 325

New course pharmacy education James Cook University 1998 302

New medicines assessment and introduction New Zealand hospitals 2004 267




New medicines assessment national pharmaceutical strategy New Zealand hospital 2005 271

Newborn haemorrhagic disease, prevention vitamin K3 formulation 1994 406

Newborn inadvertent administration ergometrine [letter] 1996 454

Newborn IV administration central venous catheter 1998 177

Nicotine replacement smoking cessation 1994 200

Nicotine replacement smoking cessation, quit rates hospital vs community 2002 57

Nimodipine guidelines quality use 1999 137

Nipples cracked geranium leaves 1995 538

Nitrazepam oral solution formulation [letter] 1996 371

Nitrofurantoin pulmonary and hepatic toxicity 2004 134

Nitrous oxide abuse adverse drug reactions 2000 109

Nocardiosis treatment case reports 1995 532

Non-inferiority trials new drugs and therapies comparative study 2011 16

Non-inferiority trials new drugs and therapies comparative study 2011 97

Non-malignant pain opioids prescribing patterns 1998 83

Non-medical prescribing transcribing versus prescribing [letter] 2010 80

Non-medical prescribing course supplementary, independent

prescribers

pharmacist prescribing 2010 187

Non-physician pharmacy practitioners hospitalist pharmacist inter-professional team 2012 89

Non-small cell lung cancer gefitinib resistance afatinib 2013 137

Non-therapeutic medication omissions medical and surgical patients Medication Management Plan 2011 188

Non-valvular AF older people anticoagulation 2012 228

Nose and mouth mucosa drug delivery review 1998 236

NSAIDs COX-2 inhibitors audit, rural general practice 2003 70

NSAIDs renal failure acute interstitial nephritis 2005 219

Nuclear pharmacy BPS examination report 2002 301

Nurse attitudes clinical pharmacy information

systems

2013 288

Nurse practitioner prescribing privileges PBS, MBS 2010 259

Nurses HIV therapy [editorial] 2014 179

Nursing home hospital vs community pharmacy costs of drug supply 1994 471

Nursing home medication review general practitioner acceptance 2002 227

Nursing home medication review service hospital pharmacists 1999 255

Nursing time ward stock vs unit-supply distribution 1997 22

Nutrition elderly 1996 278

OACIS renal pharmacist [letter] 2007 166

Obesity in older people hypocaloric diet, very low energy diet bariatric surgery, medications 2013 145

Objective clinical examination pre-registration pharmacists clinical competency 2003 194

Occupational hazards pesticides – adverse effects [letter] 2014 61

Occupational health and safety cytotoxics exposure, monitoring [letter] 2003 159

Octreotide raised zinc concentrations case report 1995 422

Octreotide usage [letter] 1997 250

Octreotide acetate – therapeutic use vascular diseases – drug therapy stomach diseases – drug therapy 2013 297

Ocular problems elderly 1997 239

Oesophageal disease management older people 2001 285

Off-label drug use, outpatients pilot study 1995 527

Olanzapine hypothermia 2005 216

Olanzapine schizophrenia [letter], [reply-letter] 1999 54

Olanzapine IV acute agitation emergency department 2011 135

Older hospitalised patients potentially inappropriate medications Beers criteria 2011 122

Older people non-English speaking backgrounds medicine management 2011 33

Older people peptic ulcer disease Helicobacter pylori 2011 58

Older residents' medication risk supported residential services home medicines reviews 2011 98

Omeprazole nasogastric administration 1998 174

Omeprazole proton pump inhibitor infants – colic 2014 220

Omeprazole paediatric dosing variations tablets, mixtures 2008 283

Omitted medication doses reasons for omission frequency and severity 2004 174

Oncology 21st COSA meeting 1995 466

Oncology BPS certification specialisation 2000 118

Oncology BPS examination examination process 1999 338

Oncology clinical report 1995 473

Oncology COX-2 inhibitors celecoxib [letter] 2000 120




Oncology COX-2 inhibitors celecoxib [reply-letter] 2000 120

Oncology ISOPP IV report 1995 476

Oncology pharmacist activities report [letter] 1995 53

Oncology supportive care MASCC meeting 2001 [letter] 2001 236

Oncology and palliative care training outpatient oncology pharmacist [letter] 2010 246

Oncology pharmacists strategies to recruit and retain staff 2007 115

Oncology pharmacy ISOPPX 2006 2007 47

Oncology pharmacy study tour [grant report] 2014 295

Ondansetron guidelines 1995 522

Ondansetron oncology protocol [letter] 1995 53

Operating room clinical pharmacy Indian perspective [letter] 2007 78

Operating suite pharmacist antibiotic stewardship, QUM,

medication safety

waste minimisation, cost savings 2012 296

Operating suite pharmacist reduce drug expenditure [letter] 2011 332

Opioid non-malignant pain prescribing patterns 1998 83

Opioid tolerance hyperalgesia opioid tolerance 2005 291

Opportunities for hospital pharmacists methadone programs addiction and chronic diseases 1998 41

Optimal liaison pharmacist intervention facilitate home medicines review 2008 107

Oral midazolam [inform] 1995 192

Oral antineoplastics advantages, disadvantages safety issues 2005 195

Oral dose forms principles of absorption 1997 222

Oral dose forms sustained/controlled-release forms 1997 381

Oral liquid preparations from tablets [letter] 1995 52

Oral liquid preparations physicochemical stability 2007 131

Oral medication administration restrictions on oral intake modified- or controlled-release 2013 177

Oral vancomycin absorption Clostridium difficile infection renal impairment 2011 225

Organisational culture competing values framework cultural analysis in health care 2012 175

Organophosphorus compounds –

poisoning

pesticides – poisoning [letter] 2013 333

Osmolality pH SC infusions 1997 29

Osteoarthritis management older people 2002 276

Osteoporosis management elderly 1995 372

Osteoporosis pharmacological management older people 2000 111

Osteoporosis – complications femoral fractures – etiology diphosphonates – adverse effects 2014 35

Osteoporosis in older people falls risk, exercise, hip protectors bisphosphonates, calcium,

teriparatide, vitamin D

2010 229

Outpatient heart failure pharmacy service 2008 103

Outpatient off-label drug use pilot study 1995 527

Outpatient oncology pharmacist online training oncology and palliative care [letter] 2010 246

Overdose hospital admissions 1994 231

Overdose moclobemide [inform] 1996 272

Overdose passage of stools documentation [letter] 1996 372

Over-the-counter medicines pharmacy practice consumer attitudes 2014 224

Oxycodone post-caesarean section analgesia safety in breastfeeding 2009 104

Paclitaxel compatibility EVA minibags glucose, NaCl injections 1998 156

Paclitaxel occupational exposure decontamination reagent latex and nitrile gloves 2009 181

Paediatric adverse drug reactions frequency 2003 106

Paediatric conference report NPPG Conference 2000 2001 64

Paediatric dosing devices accuracy 1997 323

Paediatric exchange program RCH (Melbourne) & LTH (UK) 2001 44

Paediatric repair lacerations topical agents 1995 356

Paediatric spironolactone oral solution formulation, stability 1997 390

Paediatric clopidogrel 1mg/mL

suspension

chiral stability Ora-Sweet, Ora-Plus, amber glass

bottles

2012 103

Paediatric corticosteroids mixtures comparison (taste, administration) 1998 246

Paediatric inpatients adverse drug events, medication

errors

regular medications, infusion, age 2010 290

Paediatric inpatients unregistered, off-label drug use 1999 265

Paediatric mixtures corticosteroids flavouring [letter] 1998 290

Paediatric oncology conference report SIOP Congress 2000 2001 66

Paediatric pharmacy e-mail network experience over18 months 2001 139

Paediatric pharmacy reference group [letter] 1998 289




Paediatric pharmacy total parenteral nutrition study tour - Nth America 2001 307

Paediatric pharmacy practice history, advocacy, education, training service provision, equity of access 2013 45

Paediatric psychiatry conference report CINP 2000 2001 234

Paediatrics abstracts – trends congresses and conferences –

Australia

2014 22

Paediatrics documentation pharmacists’ intervention 2014 205

Paedpharm paediatric pharmacy network paediatric pharmacists 2009 290

Pain cancer analgesia 1996 113

Pain chronic, elderly review 1998 361

Pain narcotic, paracetamol requirements post-operative 1995 13

Pain Ninth World Congress conference report 2000 286

Pain post-operative elderly 1995 280

Pain post-operative relief 1996 121

Pain management pharmacotherapy older people 2007 63

Pakistan malaria eradication [letter] 2011 73

Palliative care cultural competence [editorial] 2014 78

Palliative care drug delivery 1994 74

Palliative care elderly drug management 1998 45

Palliative care Europe 1995 272

Palliative care European Congress conference report 2001 232

Palliative care nebulised morphine dyspnoea, pilot study 1996 545

Palliative care pharmacists professional role 2014 120

Palliative care syringe infusion pump evaluation 1994 400

Palliative care patients nausea and vomiting management prescribing antiemetics 2007 306

Pancreatic enzymes high- vs standard-dose capsules cystic fibrosis 1998 160

Parabens binding sodium carboxymethylcellulose 1996 552

Paracetamol compliance with prescribing policies NSW Health paracetamol policy 2009 122

Paracetamol paediatrics safe use promotion 2006 297

Paracetamol post-operative pain orthopaedics 1995 13

Paracetamol and ibuprofen pharmacology and pharmacokinetics paediatric pain and fever 2009 223

Paracetamol tablet stability in dose administration aids ambient and accelerated conditions 2013 218

Parenteral nutrition conference AuSPEN 2000 176

Parenteral nutrition visual incompatibility 1994 167

Parenteral therapy home patients survey 1997 373

Parenteral therapy restrictive flow infusion devices review 1997 115

Parkinson's disease pharmacotherapy older people 2004 229

Patient care model pharmacy's role 1996 28

Patient cards minimising drug interactions antidepressants 1998 259

Patient counselling guidelines antineoplastics 2001 51

Patient discharge clinical information systems medication errors 2014 29

Patient education printed education material readability assessment tools 2003 284

Patient preferences communication medication counselling 2014 213

Patient recruitment adverse drug reaction study 2000 175

Patient safety education cancer – complementary and

alternative medicines

2014 231

Patient safety system changes required hospital pharmacy 2001 220

Patient safety, healthcare costs workplace safety culture education, training, ownership 2012 332

Patient satisfaction counselling survey 1999 162

Patient satisfaction pharmacy retail – New Zealand [editorial] 2013 259

Patient-centred care [letter] 2006 165

Patient-centred care interdisciplinary practice e-health 2012 256

Patient's drugs one-stop dispensing continuity of care, expenditure 2008 44

Patients' homes counselling project 1998 117

PBAC recommendation PBS approval availability in hospital 2011 88

PBS and ANS [letter] 2005 165

PBS brand substitution guidelines brand and generic products bioequivalent generic products 2007 292

PC preparation staff rosters algorithms 1998 232

Penicillin allergy antibiotic prescribing patterns, costs community-acquired pneumonia 2006 286

Penicillin allergy Sydney hospitals survey 1998 410

Penicillin allergy veteran's hospital 1997 296

Penicillin G – administration and dosage sodium citrate drug stability 2014 26

Peptic ulcer disease elderly review 1999 40




Peptides and proteins drug delivery review 1999 20

Performance indicators [letter] 1996 373

Performance indicators hospital pharmacy clinical & management 1998 405

Performance indicators hospital pharmacy practice 1996 89

Perhexiline paroxetine drug interaction 1998 254

Periodontum drugs medical conditions 1994 80

Perioperative pharmacists [letter] 2012 334

Personal digital assistants pharmacist intervention monitoring cost analysis 2007 30

Pesticides – adverse effects occupational hazards [letter] 2014 61

Pesticides – poisoning organophosphorus compounds –

poisoning

[letter] 2013 333

pH osmolality subcutaneous infusions 1997 29

Phaeochromocytoma phenoxybenzamine IV acute hypertension 1998 332

PHARM meetings [letter] 1997 338

Pharmaceutical technology driving forces 1999 335

Pharmaceutical Benefits Scheme APAC guidelines hospital/community bridge 1998 153

Pharmaceutical Benefits Scheme discharge medication management national APAC guidelines 2004 203

Pharmaceutical Benefits Scheme hospital use [letter] 2004 157

Pharmaceutical Benefits Scheme hospital use [letter] 2004 244

Pharmaceutical Benefits Scheme it's future [reply-letter] 2002 15

Pharmaceutical Benefits Scheme private hospitals 1. associated problems 2001 194

Pharmaceutical Benefits Scheme private hospitals 2. an alternative model 2001 262

Pharmaceutical Benefits Scheme public hospitals [editorial snapshot] 2000 45

Pharmaceutical Benefits Scheme public hospitals [letter] 2002 175

Pharmaceutical Benefits Scheme public hospitals [SHPA position statement] 2000 254

Pharmaceutical Benefits Scheme public hospitals impact 2001 295

Pharmaceutical Benefits Scheme public hospitals pilot project 1996 65

Pharmaceutical Benefits Scheme reforms public hospitals 2003 204

Pharmaceutical calculations computer-assisted learning student evaluation 1998 312

Pharmaceutical care Asthma medication use rural areas 2004 26

Pharmaceutical care clinical skills ASHP self-study 1998 387

Pharmaceutical care community pharmacy in Karachi [letter] 2011 78

Pharmaceutical care deficiencies research 1998 79

Pharmaceutical care diabetes [letter] 2003 17

Pharmaceutical care documentation 1996 215

Pharmaceutical care liaison model 1996 36

Pharmaceutical care mental health clinic 1996 250

Pharmaceutical care overview 1996 32

Pharmaceutical care plan hospital ward 1996 221

Pharmaceutical care plan medication chart as tool 2001 268

Pharmaceutical care planned approach 1996 37

Pharmaceutical care PSA [letter] 1997 412

Pharmaceutical care PSA project 1996 34

Pharmaceutical care specialisation certification [letter] 1997 336

Pharmaceutical industry evidence-based guidelines conflicts of interest 2011 179

Pharmaceutical reforms non-prescription medication

management

post-natal women 2012 22

Pharmaceutical review pharmacy resource implications public hospitals 2006 291

Pharmaceuticals NCCTG Standard preparation in hospital 1994 182

Pharmaceuticals NCCTG Standard preparation in hospital [letter] 1994 174

Pharmacist anticoagulant dosing service ambulatory care warfarin dosing 2011 208

Pharmacist attitudes prescriptive authority [editorial] 2013 256

Pharmacist conducted research 2011 263

Pharmacist medication review clinic dialysis centre improved medication-use 2003 199

Pharmacist prescribing [letter] 2009 82

Pharmacist prescribing Australian pharmacists’ opinion 2006 199

Pharmacist prescribing collaborative prescribing institutional de facto prescribing 2008 271

Pharmacist prescribing literature review 2004 300

Pharmacist prescribing models, competencies, training [letter] 2009 163

Pharmacist prescribing pre-operative clinic [letter] 2009 331

Pharmacist prescribing prescribing privileges hospital discharge, specialist 2005 178

Pharmacist prescribing supplementary prescribing [editorial] 2010 175




Pharmacist prescribing warfarin therapy clinical use 2008 35

Pharmacist prescribing warfarin therapy extended roles 2006 190

Pharmacist prescribing in New Zealand educational program for prescribers designated medical practitioner 2013 122

Pharmacist registration in Malaysia [letter] 2013 162

Pharmacist role chronic disease management [letter] 2007 81

Pharmacist role quality use of medicines 2004 201

Pharmacist shortage SHPA (Victoria) job register [letter] 2002 175

Pharmacist training in Nepal [letter] 2012 247

Pharmacist-only medicines community pharmacists' views New Zealand 2004 282

Pharmacists dietary supplementation – in

pregnancy

professional knowledge – evaluation 2014 113

Pharmacists immunisation professional role 2013 292

Pharmacists professional role health policy – legislation and


2014 125

Pharmacists professional role palliative care 2014 120

Pharmacists and pharmacy students mentoring, university and workforce pharmacists shortage 2007 265

Pharmacists career success self-confidence, autonomy job satisfaction, respect, recognition 2013 29

Pharmacists in general practice remuneration, clinical ability training, existing rapport with GPs 2012 184

Pharmacists' seven roles present and publish case reports chance observations 2010 258

Pharmacists’ intervention paediatrics documentation 2014 205

Pharmacist-to-bed ratio clinical pharmacist activities discharge dispensing process 2005 106

Pharmacoeconomics choosing new medicines New Zealand 2006 12

Pharmacoeconomics drug evaluation principles, practice, education 2003 287

Pharmacoeconomics implications for pharmacists 1994 38

Pharmacoepidemiology Australian course [letter] 1995 52

Pharmacoepidemiology available courses 2007 127

Pharmacoepidemiology role for hospital pharmacists biomedical literature interpretation 2010 256

Pharmacoepidemiology research hospital pharmacy dispensing records late gestation exposure to

antidepressants

2010 265

Pharmacogenetics cytochrome P450 drug metabolism 2000 102

Pharmacogenomics genomics and proteomics series Part 2 of 3 2003 133

Pharmacogenomics individualised drug therapy genetic data 2006 35

Pharmacogenomics pharmacovigilance [letter] 2009 328

Pharmacokinetics Burns patients 2005 53

Pharmacokinetics digoxin study 1997 435

Pharmacokinetics Fentanyl (nasal) 2003 59

Pharmacokinetics spinal cord injury review 1995 327

Pharmacotherapeutics teaching pharmacists and doctors [letter] 2009 164

Pharmacotherapy BPS certification Australian perspectives 1998 334

Pharmacotherapy BPS certification report 2001 223



Pharmacovigilance Argentina [letter] 2004 246

pharmacovigilance Malaysian community pharmacists [letter] 2010 245

Pharmacovigilance pharmacy students in Malaysia [letter] 2009 329

Pharmacovigilance teaching in Nepal [letter] 2009 245

Pharmacy consultation 1997 417

Pharmacy contracting services 1996 522

Pharmacy emergency medicine 1997 325

Pharmacy extensions refurbishment 1994 339

Pharmacy National Medicines Week [letter] 1999 57

Pharmacy quality 1997 244

Pharmacy salary costs vs drug costs [letter] 1997 335

Pharmacy Solomon Islands 1997 473

Pharmacy support staff 1997 430

Pharmacy time drug distribution 1997 22

Pharmacy workload measurement 1997 307

Pharmacy academic workforce academic capacity [editorial] 2010 177

Pharmacy activities recording barcode scanners Activity BarCoding 2013 207

Pharmacy and pharmacology -

organisations

credentialing [editorial] 2014 11

Pharmacy clinical placement quality indicators student workplace placements 2011 118




Pharmacy education new course James Cook University 1998 302

Pharmacy education UK Modernising Pharmacy Careers

Programme

university-based education 2011 89

Pharmacy history & philosophy research 1996 331

Pharmacy history & philosophy research 1996 337

Pharmacy hospital practice Fiji 1996 392

Pharmacy interns lifelong learning continuing professional development 2012 30

Pharmacy involvement, rural hospital in the home [letter] 1998 142

Pharmacy liaison extended communication 1997 398

Pharmacy medication safety committee [letter] 2008 81

Pharmacy practice community liaison Illawarra region 1999 217

Pharmacy practice consumer attitudes over-the-counter medicines 2014 224

Pharmacy practice general practice setting primary care 2014 240

Pharmacy practice Marshall Islands pharmacy practice 2003 216

Pharmacy practice population modelling fundamentals 1999 88

Pharmacy practice practitioner-researcher research, teaching, training 2012 5

Pharmacy practice public health service development 1999 118

Pharmacy practice rural remote 1998 301

Pharmacy practice rural Gippsland [letter] 2009 327

Pharmacy practice specialist skills [editorial snapshot] 2000 44

Pharmacy practice Tanzania 2005 205

Pharmacy practice technicians [letter] 1999 347

Pharmacy practice Vanuatu 2006 212

Pharmacy practice research Felicity J Smith, author [book review] 2011 82

Pharmacy profession regulation Australian Pharmacy Council national pharmacy register 2007 174

Pharmacy resources antibiotic policies survey 1999 92

Pharmacy retail – New Zealand patient satisfaction [editorial] 2013 259

Pharmacy service ambulatory care facilities stem cells – transplantation 2014 105

Pharmacy service research – organisations [letter] 2014 63

Pharmacy service – administration leadership [grant report] 2014 167

Pharmacy service – economics –

Australia

hospitals – Australia [editorial] 2014 4

Pharmacy services collocated hospitals private hospital practice 2000 256

Pharmacy services emergency department 2007 27

Pharmacy services future conference presentation 1999 31

Pharmacy services hospital in the home survey 1999 16

Pharmacy services private practitioners [letter] 1994 281

Pharmacy services – after hours A PINCH drug information 2014 201

Pharmacy student placements nurturing future pharmacists with improved communication 2008 121

Pharmacy students Asia-Pacific [letter] 2005 329

Pharmacy students education [editorial snapshot] 2000 45

Pharmacy students mature age no encouragement of [letter] 2003 159

Pharmacy support staff time use study 1998 436

Pharmacy technician cell-based therapies treatment of cancer 2003 296

Pharmacy technician clinical pharmacy support roles research 2003 186

Pharmacy technician clinical roles range and extent of activities 2005 119

Pharmacy technician cytotoxics handling guidelines 1998 356

Pharmacy technician emergency department [letter] 2003 16

Pharmacy technician hospital program Charles Sturt University [letter] 2003 16

Pharmacy technician medication delivery rural/regional hospital 2010 199

Pharmacy technician private hospital role expansion 2004 131

Pharmacy technician training program [letter] 2004 73

Pharmacy technician visit to RPH 2001 305

Pharmacy technicians administrative support 1996 70

Pharmacy technicians assisting with ward admissions 2001 130

Pharmacy technicians expanding roles 1994 84

Pharmacy technicians experience [letter] 2004 331

Pharmacy technicians management's expectations 1996 62

Pharmacy technicians perspective of casemix 1996 68

Pharmacy technicians pharmacy practice [letter] 1999 347

Pharmacy technicians professional role scope of practice 2014 95

Pharmacy technicians program federal conference 1996 62




Pharmacy technicians survey 1997 430

Pharmacy technicians total parenteral nutrition 1996 67

Pharmacy technicians training Australia 1996 71

Pharmacy technicians training program evaluation 1997 455

Pharmacy technicians training program SHPA (NSW Branch) 1996 635

Pharmacy workforce recruitment and retention Australian area health service 2008 183

Pharmacy workforce service delivery New Zealand hospitals 2006 271

PharmD education, postgraduate [letter] 1999 121

PharmD education, postgraduate The University of Queensland 1999 284

PharmD program pharmacy curriculum and syllabus Middle East and Asia 2011 176

Phenobarbitone oral liquid properties paediatric formulation 2008 28

Phenotyping thiopurine therapy clinical practice 2008 188

Phenoxybenzamine IV phaeochromocytoma acute hypertension 1998 332

Phenylephrine cophenylcaine forte nasal spray cardiovascular effects 1995 417

Phenylpropanolamine – administration

and dosage

syringes drug stability 2014 89

Phenytoin infusion stability and administration 2004 272

Phenytoin stability [letter] 2005 80

Philosophy history pharmaceutical research 1996 331

Philosophy history pharmaceutical research 1996 337

Phone-in1998 National Medicines Week [letter] 1999 55

Physician computerised order entry strategic issues for pharmacists 1996 664

Physician attitudes clinical pharmacy information

systems

2013 288

Physicians' attitudes roles of community pharmacist Lebanon 2004 18

Phytomenadione IV anaphylactic shock 1997 146

Pictorial asthma action plans children with chronic asthma comprehension, adherence 2010 92

Pindolol antidepressant augmentation review 1999 146

Placebo choking phobia use of placebo tablets 2001 121

Plastic infusion systems insulin concentrations 1995 129

Platelets danazol [inform] 1995 292

Pneumocystis carinii pneumonia prophylaxis [inform] 1995 46

Pneumonia – community-acquired –

drug therapy

practice guidelines guideline adherence – New Zealand 2013 272

Pneumonia severity scores PSI, CURB-65, CORB, SMART-

COP

community-acquired pneumonia 2013 97

Pneumonia, community-acquired antimicrobial therapy DUE 1999 317

Point-of-care testing capillary blood sample warfarin management 2008 300

Poisoning clinical pharmacy intervention India 2001 26

Poisoning databases [letter] 2014 162

Poisons database developing countries [letter] 2013 247

Poisons information centres conference report EAPCTT Congress 2000 2001 62

Poisons information centres guidelines SHPA, quality assurance 1995 460

Poisons information centres guidelines SHPA, quality assurance 1996 442

Poisons information centres information sources guidelines 1995 163

Poisons information centres Victorian PIC review 2001 151

Polygeline adverse drug reactions documentation 2000 107

Polypharmacy decision support systems, clinical Inappropriate prescribing – evaluation

– in old age

2013 312

Polypharmacy hospital (major, teaching) analysis 1998 432

Polypharmacy medication-related problems elderly 2014 258

Popper history & philosophy pharmaceutical research 1996 331

Population modelling pharmacy practice fundamentals 1999 88

Population-based record linkage medications used during pregnancy risks, benefits 2010 46

Port Arthur tragedy [letter] 1996 370

Post-discharge \ medication reviews home medicines review hospital initiated medication reviews 2012 268

Post-discharge HMRs impact hospital medication liaison service medication misadventure 2007 111

Postgraduate education business [letter] 2002 180

Postgraduate education forum 1994 52

Postgraduate education future needs 2000 121

Postgraduate study WHO 8 Star Pharmacist [letter] 2012 249

Postnatal depression progesterone case report 2000 21




Postoperative care intensive care units heart surgery 2014 108

Postoperative nausea and vomiting 5-HT3 antagonists 2003 275

Postoperative nausea and vomiting prophylaxis and treatment 2000 157

Post-operative pain relief 1996 121

Postoperative period warfarin – administration and dosage International Normalised Ratio 2013 276

Potassium foscarnet stability [letter] 1996 560

Potassium chloride IV current hospital practice health workers' risk of exposure 2008 19

Potential drug interactions emergency department patients emergency medicine pharmacist 2006 266

Practice guidelines guideline adherence – New Zealand community-acquired pneumonia –

drug therapy

2013 272

Practice guidelines statins – adverse effects – in old age geriatric pharmacy 2014 138

Pre-admission clinic pharmacist charting service pharmacist prescribing 2011 102

Pre-admission surgical clinic pharmacist review [letter] 2011 75

Preceptorship trauma – education [grant report] 2014 165

Prednisolone oral solution stability 1994 397

Prednisolone high-dose hyperglycaemia induction COPD exacerbations 2009 50

Pre-emptive discharge prescriptions pharmacist-generated order cost and time saving 2006 111

Pregnancy/lactation drugs Motherisk Program, Canada 2001 230

Premedication surgical practice survey, Australia 1999 206

Pre-registrant training post-BPharm [letter] 2008 79

Pre-registrant training supervised wards future clinical pharmacists 2008 47

Pre-registration pharmacists objective structured examination clinical competency 2003 194

Prescribing drug use quality review 1998 24

Prescribing transdermal glyceryl trinitrate survey 1995 197

Prescribing antipsychotics for young

people

antipsychotic monitoring program intellectual disability, autism

spectrum disorder

2013 190

Prescribing by doctors in teaching

hospitals

social and cultural influences professional subcultures, underlying

beliefs

2008 286

Prescribing decisions hospital, teaching factors influencing 1999 311

Prescribing errors emergency department pharmacist medication history and reconciliation 2007 284

Prescribing for older people ethics and practicalities decrease in quality of life 2008 64

Prescribing guidelines proton pump inhibitors concordance 2002 31

Prescribing improving audit drug use psychotropics 1998 13

Prescribing in older frail people medical ethics clinical trial data 2010 148

Prescribing indicators elderly hospital inpatients 2001 19

Prescribing medication incidents data management, reporting processes feedback reporting 2004 190

Prescribing patterns consumption of medication rural community in Mexico 2003 330

Prescribing practices National Inpatient Medication Chart emergency departments 2011 113

Prescribing quality elderly inpatients, survey 2003 101

Prescribing restrictions antibiotics outcome 1995 139

Prescribing, rational emergency department junior medical officers 2000 262

Prescription interventions New Zealand community pharmacies [letter] 2009 162

Prescription medicines advertising consumers 2000 295

Prescription writing private hospitals [letter] 1999 216

Prescriptions checking dispensing 1997 321

Prescriptive authority pharmacist attitudes [editorial] 2013 256

Presentation skills key factors pharmacists 1998 121

Primary care pharmacy practice general practice setting 2014 240

Primary care reforms MBS, PBS, GP super clinics primary care clinical pharmacists 2010 261

Primary health care GPs/pharmacists medicines advice seniors' preference 2013 7

Primary health care professional role [editorial] 2014 6

Primary pulmonary hypertension treatment 2002 185

Privacy medication data managing complexity 1998 2

Private health insurance careers 1998 268

Private hospitals drug use indicators 2005 28

Private hospitals prescription writing [letter] 1999 216

Private NSW hospitals pharmacy services 2007 119

Privatisation commercialisation corporatisation 1996 45

Privatisation health care government policy 1998 108

Privatisation public hospitals 1996 49

Privatisation repatriation hospital pharmacy 1996 47

Professional association career opportunities 1999 46




Professional compliance administration, intravenous infusion pumps 2013 279

Professional development advanced, consultant level framework advanced pharmacy practice 2011 17

Professional knowledge – evaluation pharmacists dietary supplementation – in

pregnancy

2014 113

Professional role health policy – legislation and


pharmacists 2014 125

Professional role palliative care pharmacists 2014 120

Professional role primary health care [editorial] 2014 6

Professional role scope of practice pharmacy technicians 2014 95

Professional transgressions Australian pharmacy acts professional misconduct 2009 192

Progesterone postnatal depression case report 2000 21

Prolonged oral corticosteroids osteoporosis treatment primary and secondary prevention 2006 29

Prophylaxis antibiotic surgical 1999 5

Prophylaxis antibiotics surgery 1997 290

Prophylaxis nausea in oncology ondansetron protocol [letter] 1995 53

Prophylaxis pneumocystis carinii pneumonia [inform] 1995 46

Proteomics genomics drug development 2003 7

Protocol ondansetron nausea [letter] 1995 53

Proton pump inhibitor infants – colic omeprazole 2014 220

Proton pump inhibitors prescribing guidelines concordance 2002 31

PSA pharmaceutical care [letter] 1997 412

Pseudoephedrine purchasers New Zealand experience report to police 2007 19

Psychiatric pharmacy guidelines 1995 347

Psychiatric pharmacy Psych. Pharmacy Fellowship 2000 Janssen-Cilag (report) 2002 303

Psychiatric unit risperidone usage 1997 33

Psychiatric units – South Australia drugs, prescription self-medication 2013 269

Psychiatry BPS certification Australian perspectives 1998 334

Psycholinguistic theories look-alike sound-alike errors [letter] 2009 246

Psychotropics blurred vision [inform] 1995 47

Psychotropics drug usage evaluation survey 2000 196

Psychotropics mental health disorders older people 2007 153

Psychotropics prescribing audit 1998 13

Psychotropics vision blurred [inform] 1995 47

Public health roles and opportunities education 2004 290

Public health pharmacy practice career opportunities service development 1999 118

Public hospitals complementary medicines policies 2000 23

Public hospitals data collection study SHPA, drug utilisation 1996 59

Public hospitals PBS pilot project 1996 65

Public perception Indian community pharmacies [letter] 2005 331

Publishing careers 1998 368

Publishing how to get published 1994 410

Publishing SHPA Federal Conference publication rate of abstracts 2003 111

Pulmonary drug delivery review 1998 19

Pulse IV cyclophosphamide lupus nephritis SLE 2012 278

Pump syringe infusion evaluation 1994 400

Qatari community pharmacies pharmacy practice [letter] 2013 79

Quality poisons information centres SHPA guidelines 1996 442

Quality assurance aseptic dispensing audit 1998 329

Quality health care ACHS 1996 86

Quality hospital pharmacy review 1998 226

Quality improvement conference pharmacy practice 2003 218

Quality improvement health care European forum 2005 199

Quality information medication liaison 1997 362

Quality of life neuralgia – drug therapy neuralgia – diagnosis 2014 38

Quality pharmacy US study tour 1997 244

Quality use of medicine rural [letter] 1999 347

Quality use of medicines federal government support 1996 55

Quality use of medicines mapping project QUM research not recorded 2002 141

Quality use of medicines paediatrics [letter] 2004 330

Quality use of medicines pharmacists role 2004 201

Quality use of medicines in Malaysia generic medicines [letter] 2007 334

Radiopharmacy career opportunities 2000 74




Ranitidine adverse drug reaction thrombocytopenia 2000 172

RDGAC SHPA grants program member service 2005 201

Readership survey 1997 348

Readmissions drug-related 1995 400

Recombinant erythropoietin anaemia of prematurity commencement time 2007 217

Reference group paediatric pharmacy [letter] 1998 289

Referencing incompatibilities drug combinations [letter] 1997 470

Regional renal pharmacy Aboriginal patients [letter] 2010 165

Regulation therapeutic goods trans-Tasman [letter] 2002 257

Rehabilitation aged care pharmacy costs 1996 325

Rehabilitation patients weekend leave 1995 149

Renal disease ACE inhibitors nephroprotective in diabetes 1995 410

Renal failure secondary hyperparathyroidism bone disease [letter] 2005 332

Renal function enoxaparin dose peak anti-Xa levels 2004 14

Renal pharmacist OACIS [letter] 2007 166

Renal pharmacy education northern Queensland [letter] 2009 246

Renal preceptorship [letter] 2004 158

Reporting and writing case reports [letter] 1998 68

Research clinical hospital pharmacists' place conference symposium 1998 348

Research coordinator appointment 1994 291

Research coordinator initiative 1994 59

Research grants SHPA 1999 249

Research hospital pharmacy practice 1996 52

Research pharmaceutical history & philosophy 1996 331

Research pharmaceutical history & philosophy 1996 337

Research quality use of medicines 1996 55

Research reproducing 1994 77

Research – organisations pharmacy service [letter] 2014 63

Research output Journal Citation Report Excellence in Research in Australia 2012 172

Residential care medication management hospital pharmacists 1995 541

Resistance warfarin causes [Inform] 1995 488

Resource management clinical pharmacy [editorial snapshot] 2000 46

Respiratory inhalers health professionals' techniques asthma, COPD 2010 211

Respiratory rehabilitation clinical pharmacy pharmacy input 1998 181

Respiratory tract infections – symptoms respiratory tract infections – therapy [letter] 2014 62

Respiratory tract infections – therapy respiratory tract infections –

symptoms

[letter] 2014 62

Restricted antimicrobial use ICU discharges to wards adherence to guidelines 2011 283

Restructuring hospitals implications for pharmacists 1996 22

Review adverse drug reaction labels medical records 1994 333

Review antidepressant usage 1994 250

Review drug distribution automated systems 1995 230

Review drug distribution current practice 1995 119

Review drug utilisation cephalothin 1995 238

Review drug utilisation filgrastim 1995 336

Review medication histories by pharmacist 1995 261

Review postoperative nausea and vomiting prophylaxis and treatment 2000 157

Review prescribing, administration multidisciplinary 1994 260

Rheumatoid arthritis treatment in the elderly 2005 151

Risperidone galactorrhoea [inform] 1995 548

Risperidone schizophrenia 1996 93

Risperidone usage in acute care 1997 33

Rivaroxaban – adverse effects haemorrhage – chemically induced stroke – chemically induced 2014 129

Rural quality use of medicine [letter] 1999 347

Rural and remote hospital pharmacy recruitment and retention seamless care 2012 89

Rural BPharm course pharmacy indicative curriculum rural workforce 2010 275

Rural clinical pharmacy vision for the future 2001 46

Rural community pharmacy practice Western Australia (2002 and 2006) pharmacist characteristics 2012 26

Rural health education career opportunities series 1999 117

Rural hospital pharmacy management challenges survey 1999 202

Rural initiatives [letter] 1999 291

Rural pharmacists challenges, recruitment, retention [letter] 2010 164




Rural pharmacy practice remote 1998 301

Rx for Change database impact of interventions quality of prescribing, medicines use 2011 295

Safe handling of cytotoxics practice standards [letter] 2005 166

Safety, drug cabinets cytotoxic [letter] 1999 291



Salary pharmacist, remuneration survey [letter] 1997 335

Salary costs vs drug costs [letter] 1997 335

Salicylates topical warfarin interaction [letter] 1996 671

San Antonio Breast Cancer Symposium

2013

American Society of Hematology

Annual Meeting 2013

[grant report] 2014 293

Saudi community pharmacists [letter] 2013 165

Saudi community pharmacists MDI technique [letter] 2012 77

Schedule 8 liquid medicine

discrepancies

measuring techniques, monitoring,

reporting

volume loss 2013 194

Schizophrenia treatment 1996 93

Science and medicine [letter] 2004 330

Scope of practice pharmacy technicians professional role 2014 95

Self-administration guidelines SHPA 2002 324

Self-medication psychiatric units – South Australia drugs, prescription 2013 269

Self-reported antibiotic allergy prevalence and validity emergency department 2008 92

Separation of dispensing Malaysia [letter] 2011 163

Sepsis aminoglycosides, vancomycin beta-lactams [letter] 2009 78

Serotonergic agents brain injury, hypoxic dopaminergic agents 2000 202

Severe community-acquired pneumonia paediatric educational intervention 2005 183

SHPA Federal Conference publishing publication rate of abstracts 2003 111

SHPA grants program RDGAC member service 2005 201

SHPA Medal of Merit 2014 Kirstie Galbraith oration 2014 300

SHPA member services content and direction of the journal 2012 93

SHPA Professional Development

Framework

continuum to advanced practice APPF, CPD, clinCAT 2012 259

SHPA strategic plan 1998-2000 Part 1 1999 244



Site-specific (small molecules) drug delivery [review] 1998 417

Skin adverse drug reactions review article 2003 12

Skin education for pharmacists 1997 420

Skin exposure hydrofluoric acid first aid 1998 445

Smart infusion pumps IV medication administration errors Alaris GP pumps with Guardrails 2011 192

Smoking cessation nicotine 1994 200

Smoking cessation nicotine replacement, quit rates hospital vs community 2002 57

Smoking cessation PTSD related nightmares [letter] 2009 331

Sodium bicarbonate oral vs IV contrast-induced nephropathy risk cardiology and renal patients 2012 118

Sodium carboxymethylcellulose binding to parabens oral liquid formulations 1996 552

Sodium citrate drug stability penicillin G – administration and

dosage

2014 26

Software patient costing pharmacy perspective 1996 315

Solid organ transplant pharmacist fellowship training in the USA 2013 174

Solomon Islands pharmacy training 1997 473

Special Access Scheme hospital impact 1994 307

Special Access Scheme written consent [letter] 1994 281

Specialisation BPS certification Australian perspectives 1998 334

Specialist skills pharmacy practice [editorial snapshot] 2000 44

Spinal injured patients pharmacokinetics, review 1995 327

Spironolactone oral solution stability 1997 390

SSRIs anticonvulsants [inform] 1996 587

SSRIs SIADH secretion 1996 358

SSRIs stroke, post-stroke emotionalism [letter] 2000 175

Stability phenylpropanolamine –


phenylpropanolamine –


2014 89

Stability testing formulated products 1995 405

Stability trials degradation [letter] 1996 289




Stability vitamin K1 injection, oral 1996 641

Stability of formulated mixtures Coumadin, Marevan, warfarin

powder

preservative, shelf-life 2007 95

Stability of refrigerated medicines cold chain emergencies in hospital monitoring and maintaining 2010 31

Staff support survey 1997 430

Staff rosters PC preparation algorithms 1998 232

Standard preparation pharmaceuticals [letter] 1994 174

Standard preparation pharmaceuticals [letter] 1994 182

Standard treatment guidelines essential medicines list [letter] 2010 331

Standardisation pharmacy practice definitions [editorial] 1999 135

Standards of practice clinical oncology pharmacy services 2002 115

Standards of practice clinical pharmacy 2005 122

Standards of practice clinical pharmacy supplement 2011 144

Standards of practice community liaison 1996 570

Standards of practice consumer medicines information 2000 225

Standards of practice consumer product information hospitals, SHPA 1996 434

Standards of practice distribution of medicines 2006 128

Standards of practice drug information service 1999 171

Standards of practice drug usage evaluation 1996 240

Standards of practice drug usage evaluation 1997 140

Standards of practice drug use evaluation 2004 220

Standards of practice emergency medicine pharmacy 2006 139

Standards of practice format 1995 156

Standards of practice hospital pharmacy outpatient services 2006 220

Standards of practice investigational drugs services 1999 227

Standards of practice investigational drugs services 2006 46

Standards of practice liaison pharmacist 1996 570

Standards of practice medication safety 2012 300

Standards of practice oncology pharmacist 1995 455

Standards of practice palliative care pharmacy services 2006 306

Standards of practice pharmacy management 1995 156

Standards of practice poisons information centres 1995 161

Standards of practice provision of consumer medicines info 2007 56

Standards of practice provision of medication reconciliation 2007 231

Standards of practice provision of oral chemotherapy for treatment of cancer 2007 149

Standards of practice psychiatric pharmacy 2000 292

Standards of practice safe handling of cytotoxic drugs 1999 108

Standards of practice safe handling of cytotoxic drugs 2005 44

Standards of practice SHPA format 1995 156

Standards of practice transportation of cytotoxic drugs from pharmacy departments 2000 116

Standards of practice transportation of cytotoxic drugs from pharmacy departments 2007 234

Statin therapy myalgia incidence dose related 2009 202

Statins – administration and dosage cardiovascular diseases – prevention

and control

[letter] 2014 64

Statins – adverse effects communications media [editorial] 2013 258

Statins – adverse effects – in old age geriatric pharmacy practice guidelines 2014 138

Statins – therapeutic use coronary disease – drug therapy [letter] 2013 332

Stem cells – transplantation pharmacy service ambulatory care facilities 2014 105

Stomach diseases – drug therapy octreotide acetate – therapeutic use vascular diseases – drug therapy 2013 297

Stools passage overdoses [letter] 1996 372

Stroke patient management older people 2000 60

Stroke – chemically induced rivaroxaban – adverse effects haemorrhage – chemically induced 2014 129

Student assessments forum 2005 211

Study tour oncology pharmacy [grant report] 2014 295

Study tour renal [letter] 2005 79

Subcutaneous infusions morphine, ketamine [letter] 1995 352

Subcutaneous infusions osmolality, pH 1997 29

Subcutaneous infusion disposable pump Surefuser 1998 241

Sulfur compounds – adverse effects adverse drug event [letter] 2013 332

Sumatriptan breastfeeding [inform] 1996 460

Super-warfarin poisoning [case report] 2005 56

Support staff survey 1997 430




Support staff training program 1997 455

Supportive care oncology [letter] 2005 329

Surgery antibiotic prophylaxis guidelines 1997 290

Surgical antibiotic prophylaxis Indian hospital [letter] 2006 163

Surgical practice premedication survey, Australia 1999 206

Surgical preadmission clinic pharmacist quality use of medicines medication history, reconciliation 2011 212

Survey APAC guidelines implementation levels 2003 93

Survey clinical pharmacy services national 1996 416

Survey drug information centres Australia 1995 433

Survey imported drugs, Australia pharmacy departments 1995 32

Survey readership report 1994 528

Symptomatic VTE adherence to prophylaxis guidelines pharmacological, mechanical

prophylaxis

2012 37

Synthetic cannabinomimetic Australian law [report] 2014 238

Syringe infusion pump evaluation 1994 400

Syringe polypropylene haloperidol stability 1997 338

Syringe polypropylene morphine stability 1997 207

Syringe polypropylene morphine stability 1997 452

Syringes drug stability phenylpropanolamine –


2014 89

Tablets formulating oral liquid preparations [letter] 1995 52

Tacrine for and against 1995 566

Tallman letters reduce medication selection errors hospital network 2008 263

Tallman letters reducing errors [letter] 2009 80

Taxus brevifolia endangered species clinical gem 1994 72

Teaching evidence-based practice [letter] 2004 73

Technology pharmaceuticals driving forces 1999 335

Temozolomide 10 mg/mL suspension preparation in final container polypropylene container, refrigerated 2012 111

Thalidomide 100 mg/10 mL suspension forced degradation room temp, protected from light 2012 115

Thalidomide suspension stability [letter] 2012 248

Therapeutic drug monitoring collaborative approach [letter] 1996 673

Therapeutic drug monitoring collaborative approach [letter] 1996 671

Therapeutic drug monitoring conference report clinical toxicology 2000 73

Therapeutic drug monitoring digoxin community liaison 1997 435

Therapeutic drug monitoring evaluation, comparison of two models pharmacy and pharmacology services 2004 109

Therapeutic drug monitoring HIV therapy 2004 188

Therapeutic drug monitoring pharmacist involvement [letter] 1996 671

Therapeutic goods regulation trans-Tasman [letter] 2002 257

Thiopurines inflammatory bowel disease pharmacogenetics 2005 213

Thromboembolism – prevention and

control

ambulatory care [letter] 2014 163

Thromboprophylaxis pharmacological 1994 285

Thyroid disease diagnosis and management older people 2003 228

Thyroxine dosage monitoring thyroid stimulating hormone 1999 142

Tianeptine depression 1996 98

Ticarcillan/clavulanate compliance, prescribing guidelines improve prescribing 2006 210

Ticarcillin/clavulanate incompatible with vancomycin [letter] 1997 470

Ticarcillin/clavulanate prescribing patterns non-compliant prescribing 2011 221

Time use pharmacy support staff study 1998 436

Tobramycin dosing cystic fibrosis paediatric patients pharmacokinetic model 2011 183

Tobramycin+vancomycin bone cement renal effects hip or knee arthroplasty 2008 140

Tomorrow’s Pharmacist: Registration

Exam Questions III

Bukhari N, Elsaid N, authors [book review] 2014 304

Topical agents lacerations paediatric 1995 356

Topical haemostatic agents unit dose containers [letter] 2000 229

Total parenteral nutrition paediatric pharmacy study tour of North America 2001 307

Total parenteral nutrition technician's role 1996 67

Total parenteral nutrition trace elements incompatibilities 1998 112

Total parenteral solution crystal precipitation potassium sulphate 1998 444

Toxicity herbal medicine [letter] 2000 71

Toxicology handbook Murray L, Daly F, Little M, Cadogan, M, editors [book review] 2011 164

Trace elements albumin incompatibility 2000 71




Trace elements total parenteral nutrition incompatibilities 1998 112

Tramadol adverse drug reactions use in children 2005 187

Tranquilliser use in elderly patients characteristics of use clinical correlates, dependence 2004 183

Transdermal drug delivery 1997 441

Transdermal drug delivery systems medication errors [letter] 2010 332

Trans-Tasman harmonisation initiative non-prescription medicine purchase purchasing in community pharmacies 2007 277

Trauma – education preceptorship [grant report] 2014 165

Travel medicine elderly general advice 1999 222

Tribute Ian Brand [letter] 2000 73

Trimethorim and plasma potassium urinary tract infections creatinine, urea 2010 180

Unapproved indications TGA [editorial] 2010 88

Unfractionated heparin protocols errors and near misses prescribing and administration 2008 209

Unit dose distribution systems review 1995 230

Unit dose containers topical haemostatic agents [letter] 2000 229

Unit-supply nursing and pharmacy time errors 1997 22

University training clinical testing [letter] 1997 470

Unnecessary medicines storage safety, confusion, inappropriate use medicine wastage 2006 16

Unregistered, off-label paediatric inpatients drug use 1999 265

Unstable angina and non-Q wave MI LMWH anti-factor Xa activity 2012 166

Urinary incontinence pharmacological management older people 2004 319

Urinary tract infection elderly management 1999 166

Urokinase alteplase thrombosed catheters [letter] 2002 94

US pharmacists risk evaluation, mitigation strategies drug development approval 2011 5

US study career opportunities research fellowship 1999 344

Vaccination Hib, splenectomised patients [inform] 1995 489

Vaccination influenza elderly 1995 36

Vaccination measles, mumps, rubella controversy 1998 443

Vaccination in older people influenza, pneumococcal, herpes zoster, tetanus 2012 316

Vale Lance Jeffs 2002 271

Vale Neil Naismith 2002 96

Vale Pam Neiman 2007 181

Valproate-meropenem interaction reduction in valproate concentration avoid co-administration 2012 140

Vancomycin adherence to guidelines under-dosing 2011 278

Vancomycin adverse drug reactions adverse effects 1995 257

Vancomycin continuous infusion pharmacokinetics, ICU patients 2001 108

Vancomycin continuous vs intermittent dosing [letter] 2003 18

Vancomycin drug prescribing improving 1998 400

Vancomycin drug use evaluation guidelines local & published 1998 394

Vancomycin frusemide theophylline interaction 1999 269

Vancomycin pharmacokinetics,

pharmacodynamics

target trough levels 2003 293

Vancomycin red man syndrome paediatrics 2007 124

Vancomycin resistant enterococci prevention [inform] 1997 149

Vancomycin ticarcillin/clavulanate incompatible [letter] 1997 470

Vancomycin usage review 1997 140

Vancomycin-associated neutropenia early onset [letter] 2012 80

Vascular diseases – drug therapy stomach diseases – drug therapy octreotide acetate – therapeutic use 2013 297

Vendor-managed inventory system hospital implementation 2008 40

Venlafaxine depression 1996 98

Venlafaxine hypotension, orthostatic DUE 1999 215

Venlafaxine SIADH secretion [case report] 2002 35

Venlafaxine urinary catecholamines 1997 232

Venlafaxine hydrochloride mixtures stability and shelf-life suitable for enteral feeding tubes 2008 212

Veno-occlusive disease bone marrow transplant alteplase [inform] 1995 547

Venous thromboembolism fondaparinux, LMWH, rivaroxaban,

UFH, warfarin

pharmacogenomics, anticoagulants 2010 309

Venous thromboembolism thromboprophylaxis total hip or knee arthroplasty 2008 200

Veterans' MATES program patient-specific prescriber feedback medication-related problems 2011 316

Victorian Poisons Information Centre Poisons Information Centres review 2001 151

Victorian Poisons Information Centre therapeutic errors origin of error 2006 96

Victorian public hospitals pharmacist recruitment full-time equivalent positions 2009 293

Videoconference technology continuing education program rural pharmacists 2006 187




Vigabatrin bioavailability tablets, sachets 1996 229

Vincristine intrathecal [letter] 2004 159

Violent behavioural disturbances cognitive decline, neuropsychiatric

disorders

older hospital patients 2010 184

Vitamin B12 deficiency elderly using metformin long term prevalence 2008 111

Vitamin D deficiency residential medication management aged-care facilities 2007 194

Vitamin K1 stability injection, oral 1996 641

Vitamin K3 oral formulation haemorrhagic disease, newborn 1994 406

Vomiting ondansetron protocol oncology [letter] 1995 53

Voriconazole 1% eye drops chemical stability shelf-life 2008 179

Ward stock vs unit-supply 1997 22

Ward rounds medical officers, visiting [letter] 1999 122

Ward-based pharmacy intervention Dutch surgical patients medication reconciliation, review 2013 41

Warfarin anticoagulation in hospital patients age and disease based initiation 2007 300

Warfarin azithromycin interaction 1999 159

Warfarin brands MTHDUG [letter] 2002 259

Warfarin complementary medicine interaction 2000 23

Warfarin discharge summaries [letter] 2005 245

Warfarin elderly 1997 328

Warfarin over-anticoagulation management hospital patients 2009 13

Warfarin resistance causes [inform] 1995 488

Warfarin topical salicylates interaction [letter] 1996 671

Warfarin – administration and dosage International Normalised Ratio postoperative period 2013 276

Warfarin – administration and dosage warfarin – adverse effects International Normalised Ratio 2013 283

Warfarin – adverse effects International Normalised Ratio warfarin – administration and dosage 2013 283

Warfarin discontinuation elevated INR [letter] 2012 77

Warfarin education for older inpatients documentation and provision patient characteristics 2012 129

Warfarin management in hospital excessive anticoagulation management strategies 2008 292

Warfarin safety strategy development and implementation minimise medication mishap 2005 266

Weekend leave rehabilitation patients 1995 149

WHO High 5s Project patient safety initiatives medication reconciliation, correct site

surgery

2013 133

WHO pharmacovigilance program bleeding with dabigatran prospective monitoring [editorial] 2011 262

Wilson's disease refractory cases treatment [inform] 1995 295

Wireless communications – utilisation emergency service [letter] 2014 161

Word processor individualised medication profiles Medprofs 1995 26

Workforce hospital pharmacy snapshot of workforce/SHPA 2002 72

Workload hospital pharmacy measurement 1997 307

Workload statistics cytotoxic manufacturing 2003 68

Wound management in elderly 1997 461

Wound dressings interactive/ bioactive dressings wound bed preparation 2006 318

Ximelagatran atrial fibrillation [letter] 2006 162

Ximelagatran stroke prevention, atrial fibrillation cost effectiveness 2005 279

Zinc aminophylline incompatibility [letter] 1996 370

Zinc octreotide concentrations 1995 422

journal of pharmacy practice and research · 2016-10-30 · journal of pharmacy practice and...

Documents